<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Tamoxifen</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Tamoxifen">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Tamoxifen</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Tamoxifen</b>, sold under the brand name <b>Nolvadex</b> among others, is a medication that is used to prevent breast cancer in women and treat breast cancer in women and men.<span class="mw-ref" id="cite_ref-NCI2015_8-0"><a href="#cite_note-NCI2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is also being studied for other types of cancer.<span class="mw-ref" id="cite_ref-NCI2015_8-1"><a href="#cite_note-NCI2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It has been used for Albright syndrome.<span class="mw-ref" id="cite_ref-AHFS2015_9-0"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Tamoxifen is typically taken daily by mouth for five years for breast cancer.<span class="mw-ref" id="cite_ref-AHFS2015_9-1"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Tamoxifen</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Tamoxifen2DACS.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Tamoxifen2DACS.svg.png" data-file-width="708" data-file-height="524" data-file-type="drawing" height="185" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Tamoxifen-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Tamoxifen-3D-balls.png" data-file-width="760" data-file-height="1100" data-file-type="bitmap" height="253" width="175"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Nolvadex, Genox, Tamifen, others<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>TMX; ICI-46474</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/tamoxifen-citrate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/tamoxifen-citrate.html'" tppabs="https://www.drugs.com/monograph/tamoxifen-citrate.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a682414.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a682414.html'" tppabs="https://medlineplus.gov/druginfo/meds/a682414.html" class="external text external">a682414</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tamoxifen  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tamoxifen'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tamoxifen" class="external text external">Tamoxifen</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-0"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-1"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Selective estrogen receptor modulator</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>L02BA01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L02BA01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L02BA01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L02BA01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>~100%<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-0"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-BrennerStevens2017_4-0"><a href="#cite_note-BrennerStevens2017-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;99% (<a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a>)<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-1"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-ChabnerLongo2011_5-0"><a href="#cite_note-ChabnerLongo2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hepatic (CYP3A4, CYP2C9, CYP2D6)<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-2"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Nolvadex-Label_6-0"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-0"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• Afimoxifene<span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-1"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br>• Endoxifen<span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-2"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br>• Norendoxifen<span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-3"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>5–7 days<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-3"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-4"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces: 65%<br>Urine: 9%</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>Z</i>)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-<i>N</i>,<i>N</i>-dimethylethanamine</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=10540-29-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=10540-29-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=10540-29-1" class="external text external">10540-29-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/2733526  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/2733526'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/2733526" class="external text external">2733526</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1016'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1016" class="external text external">1016</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00675  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00675'" tppabs="https://www.drugbank.ca/drugs/DB00675" class="external text external">DB00675</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.2015313.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.2015313.html'" tppabs="http://www.chemspider.com/Chemical-Structure.2015313.html" class="external text external">2015313</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=094ZI81Y45  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=094ZI81Y45'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=094ZI81Y45" class="external text external">094ZI81Y45</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D08559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D08559'" tppabs="https://www.kegg.jp/entry/D08559" class="external text external">D08559</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41774'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41774" class="external text external">CHEBI:41774</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL83  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL83'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL83" class="external text external">ChEMBL83</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID1034187  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID1034187'" tppabs="https://comptox.epa.gov/dashboard/DTXSID1034187" class="external text external">DTXSID1034187</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.031.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.031.004'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.031.004" class="external text external">100.031.004</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>26</sub><span>H</span><sub>29</sub><span>N</span><span>O</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>371.515 g/mol<br>563.638 g/mol (citrate salt)<span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CN%28C%29CCOc1ccc%28cc1%29%2FC%28c2ccccc2%29%3DC%28%2FCC%29c3ccccc3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CN%28C%29CCOc1ccc%28cc1%29%2FC%28c2ccccc2%29%3DC%28%2FCC%29c3ccccc3'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CN%28C%29CCOc1ccc%28cc1%29%2FC%28c2ccccc2%29%3DC%28%2FCC%29c3ccccc3" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CN(C)CCOc1ccc(cc1)/C(c2ccccc2)=C(/CC)c3ccccc3</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:NKANXQFJJICGDU-QPLCGJKRSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470477095&page2=Tamoxifen  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470477095&page2=Tamoxifen'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470477095&page2=Tamoxifen" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Serious side effects include a small increased risk of uterine cancer, stroke, vision problems, and pulmonary embolism.<span class="mw-ref" id="cite_ref-AHFS2015_9-2"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Common side effects include irregular periods, weight loss, and hot flashes.<span class="mw-ref" id="cite_ref-AHFS2015_9-3"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It may cause harm to the baby if taken during pregnancy or breastfeeding.<span class="mw-ref" id="cite_ref-AHFS2015_9-4"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It is a selective estrogen-receptor modulator (SERM) and works by decreasing the growth of breast cancer cells.<span class="mw-ref" id="cite_ref-AHFS2015_9-5"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It is a member of the triphenylethylene group of compounds.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


<p>Tamoxifen was initially made in 1962, by chemist Dora Richardson.<span class="mw-ref" id="cite_ref-Viviane_M_2017_12-0"><a href="#cite_note-Viviane_M_2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Jordan_2006_13-0"><a href="#cite_note-Jordan_2006-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It is on the World Health Organization's List of Essential Medicines.<span class="mw-ref" id="cite_ref-WHO21st_14-0"><a href="#cite_note-WHO21st-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Tamoxifen is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2015_9-6"><a href="#cite_note-AHFS2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>  In 2017, it was the 251st most commonly prescribed medication in the United States, with more than one million prescriptions.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Breast_cancer">Breast cancer</h3></summary>
    
<p>Tamoxifen is used for the treatment of both early and advanced estrogen receptor-positive (ER-positive or ER+) breast cancer in pre- and post-menopausal women.<span class="mw-ref" id="cite_ref-Jordan_1993_17-0"><a href="#cite_note-Jordan_1993-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Additionally, it is the most common hormone treatment for male breast cancer.<span class="mw-ref" id="cite_ref-urlBreast_cancer_in_men:_Cancer_Research_UK:_CancerHelp_UK_18-0"><a href="#cite_note-urlBreast_cancer_in_men:_Cancer_Research_UK:_CancerHelp_UK-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It is also approved by the FDA for the prevention of breast cancer in women at high risk of developing the disease.<span class="mw-ref" id="cite_ref-FDA_19-0"><a href="#cite_note-FDA-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> It has been further approved for the reduction of contralateral (in the opposite breast) cancer. The use of tamoxifen is recommended for 10 years.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>In 2006, the large STAR clinical study concluded that <a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">raloxifene</a> is also effective in reducing the incidence of breast cancer. Updated results after an average of 6.75 years of follow up found that raloxifene retains 76% of tamoxifen's effectiveness in preventing invasive breast cancer, with 45% fewer uterine cancers and 25% fewer blood clots in women taking raloxifene than in women taking tamoxifen.<span class="mw-ref" id="cite_ref-NCI_21-0"><a href="#cite_note-NCI-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-STAR_22-0"><a href="#cite_note-STAR-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Infertility">Infertility</h3></summary>
    
<p>Tamoxifen is used for ovulation induction to treat infertility in women with anovulatory disorders. It is given at days three to seven of a woman's cycle.<span class="mw-ref" id="cite_ref-Steiner_2005_24-0"><a href="#cite_note-Steiner_2005-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>Tamoxifen improves fertility in males with infertility by disinhibiting the hypothalamic–pituitary–gonadal axis (HPG axis) via ER antagonism and thereby increasing the secretion of <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a> (LH) and follicle-stimulating hormone (FSH) and increasing testicular <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> production.<span class="mw-ref" id="cite_ref-pmid23970453_25-0"><a href="#cite_note-pmid23970453-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Gynecomastia">Gynecomastia</h3></summary>
    
<p>Tamoxifen is used to prevent and treat gynecomastia.<span class="mw-ref" id="cite_ref-Lapidvan_Wingerden2013_26-0"><a href="#cite_note-Lapidvan_Wingerden2013-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-VianiBernardes_da_Silva2012_27-0"><a href="#cite_note-VianiBernardes_da_Silva2012-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> It is taken as a preventative measure in small doses, or used at the onset of any symptoms such as nipple soreness or sensitivity. Other medications are taken for similar purposes such as <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a> and the anti-aromatase drugs which are used in order to try to avoid the hormone-related adverse effects.</p>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Tamoxifen doses and rates of bicalutamide-induced breast symptoms in men</caption>
<tbody><tr>
<th rowspan="2">Follow-up<br>timepoint</th><th colspan="6">Tamoxifen dosage</th></tr>
<tr>
<th>Placebo</th><th>1<span>&nbsp;</span>mg/day</th><th>2.5<span>&nbsp;</span>mg/day</th><th>5<span>&nbsp;</span>mg/day</th><th>10<span>&nbsp;</span>mg/day</th><th>20<span>&nbsp;</span>mg/day</th></tr>
<tr>
<td>0 months</td><td colspan="6"><div class="center" style="width:auto; margin-left:auto; margin-right:auto;">–</div></td></tr>
<tr>
<td>6 months</td><td>98%</td><td>90%</td><td>80%</td><td>54%</td><td>22%</td><td>10%</td></tr>
<tr>
<td>12 months</td><td>99%</td><td>95%</td><td>84%</td><td>56%</td><td>38%</td><td>19%</td></tr>
<tr class="sortbottom">
<td colspan="7" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Prevention of breast symptoms—specifically gynecomastia and breast pain—induced by 150<span>&nbsp;</span>mg/day <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a> monotherapy with tamoxifen in 282<span>&nbsp;</span>men with prostate cancer. Bicalutamide and tamoxifen were initiated at the same time (0<span>&nbsp;</span>months). <b>Sources:</b> <span class="mw-ref" id="cite_ref-pmid29322112_28-0"><a href="#cite_note-pmid29322112-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-pmid_29-0"><a href="#cite_note-pmid-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></td></tr>
</tbody></table>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Early_puberty">Early puberty</h3></summary>
    
<p>Tamoxifen is useful in the treatment of peripheral precocious puberty, for instance due to McCune–Albright syndrome, in both girls and boys.<span class="mw-ref" id="cite_ref-pmid29292624_30-0"><a href="#cite_note-pmid29292624-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-HaddadEugster2019_31-0"><a href="#cite_note-HaddadEugster2019-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-Zacharin2019_32-0"><a href="#cite_note-Zacharin2019-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> It has been found to decrease growth velocity and the rate of bone maturation in girls with precocious puberty, and hence to improve final height in these individuals.<span class="mw-ref" id="cite_ref-pmid29292624_30-1"><a href="#cite_note-pmid29292624-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-HaddadEugster2019_31-1"><a href="#cite_note-HaddadEugster2019-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:252px"><img src="../I/m/Nolvadex.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Nolvadex.jpg" data-file-width="2119" data-file-height="1423" data-file-type="bitmap" height="168" width="250"><div class="thumbcaption" style="text-align: left">Nolvadex (tamoxifen) 20 mg tablets.</div></div></div>

<p>Tamoxifen is available as a tablet or oral solution.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Tamoxifen has a number of contraindications, including known hypersensitivity to tamoxifen or other ingredients, individuals taking concomitant <a href="Coumarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumarin" title="Coumarin">coumarin</a>-type anticoagulant therapy, and women with a history of venous thromboembolism (deep vein thrombosis or pulmonary embolism).<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-1"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>A report in September 2009 from Health and Human Services' Agency for Healthcare Research and Quality suggests that tamoxifen, raloxifene, and tibolone used to treat breast cancer significantly reduce invasive breast cancer in midlife and older women, but also increase the risk of adverse side effects.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>
 
<p>Some cases of lower-limb lymphedema have been associated with the use of tamoxifen, due to the blood clots and deep vein thrombosis (DVT) that can be caused by this medication. Resolution of the blood clots or DVT is needed before lymphedema treatment can be initiated.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Bone">Bone</h3></summary>
    
<p>A beneficial side effect of tamoxifen is that it prevents bone loss by acting as an ER agonist (i.e., mimicking the effects of estrogen) in this cell type. Therefore, by inhibiting osteoclasts, it prevents osteoporosis.<span class="mw-ref" id="cite_ref-pmid17803905_36-0"><a href="#cite_note-pmid17803905-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-pmid18219273_37-0"><a href="#cite_note-pmid18219273-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> When tamoxifen was launched as a drug, it was thought that tamoxifen would act as an ER antagonist in all tissue, including bone, and therefore it was feared that it would contribute to osteoporosis. It was therefore very surprising that the opposite effect was observed clinically. Hence tamoxifen's tissue selective action directly led to the formulation of the concept of SERMs.<span class="mw-ref" id="cite_ref-Mincey_2000_38-0"><a href="#cite_note-Mincey_2000-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> In contrast tamoxifen appears to be associated with bone loss in premenopausal women who continue to menstruate after adjuvant chemotherapy.<span class="mw-ref" id="cite_ref-pmid16446340_39-0"><a href="#cite_note-pmid16446340-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Endometrial_cancer">Endometrial cancer</h3></summary>
    
<p>Tamoxifen is a selective estrogen receptor modulator (SERM).<span class="mw-ref" id="cite_ref-Gallo_1997_40-0"><a href="#cite_note-Gallo_1997-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> Even though it is an antagonist in breast tissue it acts as partial agonist on the endometrium and has been linked to endometrial cancer in some women. Therefore, endometrial changes, including cancer, are among tamoxifen's side effects.<span class="mw-ref" id="cite_ref-Grilli_2006_41-0"><a href="#cite_note-Grilli_2006-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> With time, risk of endometrial cancer may be doubled to quadrupled, which is a reason tamoxifen is typically only used for five years.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>The American Cancer Society lists tamoxifen as a known carcinogen, stating that it increases the risk of some types of uterine cancer while lowering the risk of breast cancer recurrence.<span class="mw-ref" id="cite_ref-ACS_43-0"><a href="#cite_note-ACS-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> The ACS states that its use should not be avoided in cases where the risk of breast cancer recurrence without the drug is higher than the risk of developing uterine cancer with the drug.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cardiovascular_and_metabolic">Cardiovascular and metabolic</h3></summary>
    
<p>Tamoxifen treatment of postmenopausal women is associated with beneficial effects on serum lipid profiles. However, long-term data from clinical trials have failed to demonstrate a cardioprotective effect.<span class="mw-ref" id="cite_ref-pmid16230014_44-0"><a href="#cite_note-pmid16230014-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> For some women, tamoxifen can cause a rapid increase in triglyceride concentration in the blood. In addition, there is an increased risk of thromboembolism especially during and immediately after major surgery or periods of immobility.<span class="mw-ref" id="cite_ref-pmid15699284_45-0"><a href="#cite_note-pmid15699284-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> Use of tamoxifen has been shown to slightly increase risk of deep vein thrombosis, pulmonary embolism, and stroke.<span class="mw-ref" id="cite_ref-Harvey_2006_46-0"><a href="#cite_note-Harvey_2006-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> Tamoxifen is also a cause of fatty liver, otherwise known as steatorrhoeic hepatosis or steatosis hepatis.<span class="mw-ref" id="cite_ref-pmid17181445_47-0"><a href="#cite_note-pmid17181445-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Central_nervous_system">Central nervous system</h3></summary>
    
<p>Tamoxifen-treated breast cancer patients show evidence of reduced cognition,<span class="mw-ref" id="cite_ref-pmid11194452_48-0"><a href="#cite_note-pmid11194452-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> and semantic memory scores.<span class="mw-ref" id="cite_ref-pmid14741674_49-0"><a href="#cite_note-pmid14741674-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> However, memory impairment in patients treated with tamoxifen was less severe compared with those treated with <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">anastrozole</a> (an aromatase inhibitor).<span class="mw-ref" id="cite_ref-pmid17898668_50-0"><a href="#cite_note-pmid17898668-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>

<p>A significant number of tamoxifen-treated breast cancer patients experience a reduction of libido.<span class="mw-ref" id="cite_ref-pmid10334535_51-0"><a href="#cite_note-pmid10334535-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-pmid16944295_52-0"><a href="#cite_note-pmid16944295-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Liver_toxicity">Liver toxicity</h3></summary>
    
<p>Tamoxifen has been associated with a number of cases of hepatotoxicity.<span class="mw-ref" id="cite_ref-CameronFeuer2012_53-0"><a href="#cite_note-CameronFeuer2012-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Several different varieties of hepatotoxicity have been reported.<span class="mw-ref" id="cite_ref-CameronFeuer2012_53-1"><a href="#cite_note-CameronFeuer2012-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Weight_gain">Weight gain</h3></summary>
    
<p>Weight gain is a commonly reported side effect,<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> but studies have not been able to find significant evidence of a correlation.<span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Acute overdose of tamoxifen has not been reported in humans.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-2"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In dose-ranging studies, tamoxifen was administered at very high doses in women (e.g., 300<span>&nbsp;</span>mg/m<sup>2</sup>) and was found to produce acute neurotoxicity including tremor, hyperreflexia, unsteady gait, and dizziness.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-3"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> These symptoms occurred within three to five days of therapy and disappeared within two to five days of discontinuation of therapy.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-4"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> No indications of permanent neurotoxicity were observed.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-5"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> QT prolongation was also observed with very high doses of tamoxifen.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-6"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> There is no specific antidote for overdose of tamoxifen.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-7"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Instead, treatment should be based on symptoms.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-8"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    

<p>Patients with variant forms of the gene CYP2D6 (also called simply 2D6) may not receive full benefit from tamoxifen because of too slow metabolism of the tamoxifen prodrug into its active metabolites.<span class="mw-ref" id="cite_ref-Goetz_2005_56-0"><a href="#cite_note-Goetz_2005-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-Beverage_2007_57-0"><a href="#cite_note-Beverage_2007-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> On 18 October 2006, the Subcommittee for Clinical Pharmacology recommended relabeling tamoxifen to include information about this gene in the package insert.<span class="mw-ref" id="cite_ref-58"><a href="#cite_note-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<p>Certain CYP2D6 variations in breast cancer patients lead to a worse clinical outcome for tamoxifen treatment.<span class="mw-ref" id="cite_ref-pmid19809024_59-0"><a href="#cite_note-pmid19809024-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Genotyping therefore has the potential for identification of women who have these CYP2D6 phenotypes and for whom the use of tamoxifen is associated with poor outcomes.</p>

<p>Recent studies suggest that taking the selective serotonin reuptake inhibitors (SSRIs) antidepressants <a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil), <a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac), and <a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">sertraline</a> (Zoloft) can decrease the effectiveness of tamoxifen, as these drugs compete for the CYP2D6 enzyme which is needed to metabolize tamoxifen into its active forms.<span class="mw-ref" id="cite_ref-Jin_2005_60-0"><a href="#cite_note-Jin_2005-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> A U.S. study presented at the American Society of Clinical Oncology's annual meeting in 2009 found that after two years, 7.5% of women who took only tamoxifen had a recurrence, compared with 16% who took either paroxetine, fluoxetine or sertraline, drugs considered to be the most potent CYP2D6 inhibitors. That difference translates to a 120% increase in the risk of breast cancer recurrence. Patients taking the SSRIs; Celexa (<a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">citalopram</a>), Lexapro (<a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">escitalopram</a>), and Luvox (<a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a>), did not have an increased risk of recurrence, due to their lack of competitive metabolism for the CYP2D6 enzyme.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> A newer study demonstrated a clearer and stronger effect from paroxetine in causing the worst outcomes. Patients treated with both paroxetine and tamoxifen have a 67% increased risk of death from breast cancer, from 24% to 91%, depending on the duration of coadministration.<span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>

<p>Recent research has shown that 7–10% of women with breast cancer may not receive the full medical benefit from taking tamoxifen due to their genetic make-up. DNA Drug Safety Testing can examine DNA variations in the CYP2D6 and other important drug processing pathways. More than 20% of all clinically used medications are metabolized by CYP2D6 and knowing the CYP2D6 status of a person can help the doctor with the future selection of medications.<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Other molecular biomarkers may also be used to select appropriate patients likely to benefit from tamoxifen.<span class="mw-ref" id="cite_ref-pmid21552410_64-0"><a href="#cite_note-pmid21552410-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>

<p>Tamoxifen interacts with certain other antiestrogens.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-4"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The aromatase inhibitor <a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">aminoglutethimide</a> induces the metabolism of tamoxifen.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-5"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Conversely, the aromatase inhibitor <a href="Letrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Letrozole" title="Letrozole">letrozole</a> does not affect the metabolism of tamoxifen.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-6"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> However, tamoxifen induces the metabolism of letrozole and significantly reduces its concentrations.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-7"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Selective_estrogen_receptor_modulator_activity">Selective estrogen receptor modulator activity</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/3ert.png" tppabs="https://ptable.com/wiki/compounds/I/m/3ert.png" data-file-width="960" data-file-height="720" data-file-type="bitmap" height="165" width="220"><div class="thumbcaption" style="text-align: left">Crystallographic structure of afimoxifene (carbon = white, <a href="Oxygen.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxygen" title="Oxygen">oxygen</a> = red, <a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">nitrogen</a> = blue) complexed with ligand binding domain of estrogen receptor alpha (ERα) (cyan ribbon).<span class="mw-ref" id="cite_ref-pmid9875847_65-0"><a href="#cite_note-pmid9875847-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></div></div></div>

<p>Tamoxifen acts as a selective estrogen receptor modulator (SERM), or as a partial agonist of the estrogen receptors (ERs). It has mixed estrogenic and antiestrogenic activity, with its profile of effects differing by tissue. For instance, tamoxifen has predominantly antiestrogenic effects in the breasts but predominantly estrogenic effects in the uterus and liver. In breast tissue, tamoxifen acts as an ER antagonist so that transcription of estrogen-responsive genes is inhibited.<span class="mw-ref" id="cite_ref-Wang_2004_66-0"><a href="#cite_note-Wang_2004-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>

<p>Tamoxifen has relatively little affinity for the ERs itself and instead acts as a prodrug of active metabolites such as afimoxifene (4-hydroxytamoxifen; 4-OHT) and endoxifen (<i>N</i>-desmethyl-4-hydroxytamoxifen). These metabolites have approximately 30 to 100 times greater affinity for the ERs as tamoxifen itself.<span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> Tamoxifen has 7% and 6% of the affinity of <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a> for the ERα and ERβ, respectively, whereas afimoxifene has 178% and 338% of the affinity of estradiol for the ERα and ERβ, respectively.<span class="mw-ref" id="cite_ref-pmid16112947_68-0"><a href="#cite_note-pmid16112947-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> Hence, afimoxifine has 25-fold higher affinity for the ERα and 56-fold higher affinity for the ERβ than tamoxifen.<span class="mw-ref" id="cite_ref-pmid15863530_69-0"><a href="#cite_note-pmid15863530-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Tamoxifen is a long-acting SERM, with a nuclear retention of the ER–tamoxifen complex of greater than 48<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-RunnebaumRabe2013_70-0"><a href="#cite_note-RunnebaumRabe2013-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span><span class="mw-ref" id="cite_ref-WallachHammond1982_71-0"><a href="#cite_note-WallachHammond1982-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>
 
<p>Afimoxifene binds to ER, the ER/tamoxifen complex recruits other proteins known as co-repressors, and the complex then binds to DNA to modulate gene expression. Some of these proteins include NCoR and SMRT.<span class="mw-ref" id="cite_ref-pmid11136970_72-0"><a href="#cite_note-pmid11136970-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> Tamoxifen function can be regulated by a number of different variables including growth factors.<span class="mw-ref" id="cite_ref-pmid18245484_73-0"><a href="#cite_note-pmid18245484-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> Tamoxifen needs to block growth factor proteins such as ErbB2/HER2<span class="mw-ref" id="cite_ref-Hurtado_2008_74-0"><a href="#cite_note-Hurtado_2008-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> because high levels of ErbB2 have been shown to occur in tamoxifen resistant cancers.<span class="mw-ref" id="cite_ref-pmid12618500_75-0"><a href="#cite_note-pmid12618500-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> Tamoxifen seems to require a protein PAX2 for its full anticancer effect.<span class="mw-ref" id="cite_ref-Hurtado_2008_74-1"><a href="#cite_note-Hurtado_2008-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-urlwww.modernmedicine.com_76-0"><a href="#cite_note-urlwww.modernmedicine.com-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> In the presence of high PAX2 expression, the tamoxifen/ER complex is able to suppress the expression of the pro-proliferative ERBB2 protein. In contrast, when AIB-1 expression is higher than PAX2, tamoxifen/ER complex upregulates the expression of ERBB2 resulting in stimulation of breast cancer growth.<span class="mw-ref" id="cite_ref-Hurtado_2008_74-2"><a href="#cite_note-Hurtado_2008-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-urlCORDIS_:_News_77-0"><a href="#cite_note-urlCORDIS_:_News-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span></p>

<p>Afimoxifene binds to ER competitively (with respect to the endogenous agonist estrogen) in tumor cells and other tissue targets, producing a nuclear complex that decreases DNA synthesis and inhibits estrogen effects. It is a nonsteroidal agent with potent antiestrogenic properties which compete with estrogen for binding sites in breast and other tissues. Tamoxifen causes cells to remain in the G<sub>0</sub> and G<sub>1</sub> phases of the cell cycle. Because it prevents (pre)cancerous cells from dividing but does not cause cell death, tamoxifen is cytostatic rather than cytocidal.</p>
 
<p>The scientific literature is complex with respect to the activity of tamoxifen, and care should be taken to establish whether tamoxifen, or afimoxifene was used, especially in <i>in-vitro</i> assays.</p>

<p>Tamoxifen has been found to decrease insulin-like growth factor 1 (IGF-1) levels by 17 to 38% in women and men.<span class="mw-ref" id="cite_ref-pmid27704479_78-0"><a href="#cite_note-pmid27704479-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> Suppression of IGF-1 production in the liver is a well-known action of estrogens and SERMs.<span class="mw-ref" id="cite_ref-pmid27704479_78-1"><a href="#cite_note-pmid27704479-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> A 10<span>&nbsp;</span>mg/day dosage of tamoxifen is nearly as effective as a 20<span>&nbsp;</span>mg/day dosage in suppressing IGF-1 levels.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-8"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>The effects of tamoxifen on breast cancer Ki-67 expression, sex hormone-binding globulin (SHBG) levels, and IGF-1 levels are dose-dependent across a dosage range of one to 20<span>&nbsp;</span>mg/day in women with breast cancer.<span class="mw-ref" id="cite_ref-pmid15755972_79-0"><a href="#cite_note-pmid15755972-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span></p>

<p>Tamoxifen is antigonadotropic in postmenopausal women and partially suppresses levels of the gonadotropins, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a> (LH) and follicle-stimulating hormone (FSH) in such women.<span class="mw-ref" id="cite_ref-pmid23687971_80-0"><a href="#cite_note-pmid23687971-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> However, it has progonadotropic effects in premenopausal women and increases estrogen levels by 6-fold in them.<span class="mw-ref" id="cite_ref-pmid23687971_80-1"><a href="#cite_note-pmid23687971-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> Due to the nature of tamoxifen as a competitive ER ligand, this increase in estrogen levels is liable to interfere with the antiestrogenic efficacy of tamoxifen.<span class="mw-ref" id="cite_ref-pmid23687971_80-2"><a href="#cite_note-pmid23687971-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span></p>

<span>
</span><table class="wikitable  mw-collapsible mw-collapsed" style="margin-left: auto; margin-right: auto; border: none;">
<caption class="nowrap"> Tissue-specific estrogenic and antiestrogenic activity of <abbr>SERMs</abbr></caption>
<tbody><tr>
<th rowspan="2">Medication</th><th rowspan="2">Breast</th><th rowspan="2">Bone</th><th colspan="4">Liver</th><th rowspan="2">Uterus</th><th rowspan="2">Vagina</th><th colspan="3">Brain</th></tr>
<tr>
<th>Lipids</th><th>Coagulation</th><th><abbr>SHBG</abbr></th><th><abbr>IGF-1</abbr></th><th>Hot flashes</th><th>Gonadotropins</th></tr>
<tr>
<td>Estradiol</td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td></tr>
<tr>
<td>"Ideal SERM"</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td>Bazedoxifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td>?</td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td>?</td></tr>
<tr>
<td><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td>?</td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Red">–</span></td><td>?</td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td>Lasofoxifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td>?</td><td>?</td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td>?</td></tr>
<tr>
<td>Ospemifene</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Limegreen">±</span></td><td><span style="color:Red">–</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td>Tamoxifen</td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Red">–</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr>
<td><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></td><td><span style="color:Red">–</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Blue">+</span></td><td><span style="color:Red">–</span></td><td><span style="color:Red">–</span></td><td><span style="color:Limegreen">±</span></td></tr>
<tr class="sortbottom">
<td colspan="15" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Effect:</b> <span style="color:Blue">+</span> = Estrogenic / agonistic. <span style="color:Limegreen">±</span> = Mixed or neutral. <span style="color:Red">–</span> = Antiestrogenic / antagonistic. <b>Note:</b> SERMs generally increase gonadotropin levels in hypogonadal and eugonadal men as well as premenopausal women (antiestrogenic) but decrease gonadotropin levels in postmenopausal women (estrogenic). <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Other_activities">Other activities</h4></summary>
    
<p>Afimoxifene is an agonist of the G protein-coupled estrogen receptor (GPER) with relatively low affinity (100–1,000<span>&nbsp;</span>nM, relative to 3–6<span>&nbsp;</span>nM for estradiol).<span class="mw-ref" id="cite_ref-pmid26023144_81-0"><a href="#cite_note-pmid26023144-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span></p>

<p>Norendoxifen (<i>N</i>,<i>N</i>-didesmethyl-4-hydroxytamoxifen), another active metabolite of tamoxifen, has been found to act as a potent competitive aromatase inhibitor (IC<sub>50</sub> = 90<span>&nbsp;</span>nM), and may also be involved in the antiestrogenic activity of tamoxifen.<span class="mw-ref" id="cite_ref-pmid23824607_82-0"><a href="#cite_note-pmid23824607-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></p>

<p>In addition to its activity as a SERM, tamoxifen is a potent and selective protein kinase C inhibitor, and is active in this regard at therapeutic concentrations.<span class="mw-ref" id="cite_ref-ZarateManji2009_83-0"><a href="#cite_note-ZarateManji2009-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> This action is thought to underlie the efficacy of tamoxifen in the treatment of bipolar disorder.<span class="mw-ref" id="cite_ref-ZarateManji2009_83-1"><a href="#cite_note-ZarateManji2009-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>

<p>Tamoxifen is an inhibitor of P-glycoprotein.<span class="mw-ref" id="cite_ref-Nolvadex-Label_6-9"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Tamoxifen is rapidly and extensively absorbed from the intestines with oral administration.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-9"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-BrennerStevens2017_4-1"><a href="#cite_note-BrennerStevens2017-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The oral bioavailability of tamoxifen is high at approximately 100%, which is suggestive of minimal first-pass metabolism in the intestines and liver.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-10"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Following intake, peak levels of tamoxifen occur after three to seven hours.<span class="mw-ref" id="cite_ref-DeVitaLawrence2016_84-0"><a href="#cite_note-DeVitaLawrence2016-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-MorelloWurz2003_3-11"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Steady state levels of tamoxifen are reached typically after three to four weeks but possibly up to 16<span>&nbsp;</span>weeks of daily administration.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-12"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Nagar2010_85-0"><a href="#cite_note-Nagar2010-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> Steady state levels of afimoxifene are achieved after 8<span>&nbsp;</span>weeks of daily tamoxifen administration.<span class="mw-ref" id="cite_ref-Nagar2010_85-1"><a href="#cite_note-Nagar2010-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-ChabnerLongo2011_5-1"><a href="#cite_note-ChabnerLongo2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>The volume of distribution of tamoxifen is 50 to 60<span>&nbsp;</span>L/kg and its clearance has been estimated as 1.2 to 5.1<span>&nbsp;</span>L/hour.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-13"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-DeVitaLawrence2016_84-1"><a href="#cite_note-DeVitaLawrence2016-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> High concentrations of tamoxifen have been found in breast, uterus, liver, kidney, lung, pancreas, and ovary tissue in animals and humans.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-14"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Levels of tamoxifen in the uterus have been found to be 2- to 3-fold higher than in the circulation.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-15"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The plasma protein binding of tamoxifen and afimoxifene is greater than 99%.<span class="mw-ref" id="cite_ref-ChabnerLongo2011_5-2"><a href="#cite_note-ChabnerLongo2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> A majority of tamoxifen is bound to <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a>.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-16"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Tamoxifen itself is a prodrug is metabolized in the liver by the cytochrome P450 isoforms CYP3A4, CYP2C9, and CYP2D6 into active metabolites such as afimoxifene and endoxifen.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-17"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Nolvadex-Label_6-10"><a href="#cite_note-Nolvadex-Label-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-5"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Tamoxifen and its metabolites undergo conjugation, including glucuronidation and sulfation.<span class="mw-ref" id="cite_ref-Nagar2010_85-2"><a href="#cite_note-Nagar2010-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> Tamoxifen may inhibit its own metabolism.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-18"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Tamoxifen has a long elimination half-life of typically five to seven days, with a range of four to eleven days.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-19"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-6"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-DeVitaLawrence2016_84-2"><a href="#cite_note-DeVitaLawrence2016-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> Similarly, the half-life of afimoxifene is 14<span>&nbsp;</span>days.<span class="mw-ref" id="cite_ref-ChabnerLongo2011_5-3"><a href="#cite_note-ChabnerLongo2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Conversely, the half-life of endoxifen is 50 to 70<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-Sanchez-SpitmanSwen2019_7-7"><a href="#cite_note-Sanchez-SpitmanSwen2019-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> The long half-lives of tamoxifen and afimoxifene are attributed to their high plasma protein binding as well as to enterohepatic recirculation.<span class="mw-ref" id="cite_ref-ChabnerLongo2011_5-4"><a href="#cite_note-ChabnerLongo2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Upon discontinuation of treatment, levels of tamoxifen and its metabolites persist in the circulation for at least 6<span>&nbsp;</span>weeks.<span class="mw-ref" id="cite_ref-ChabnerLongo2011_5-5"><a href="#cite_note-ChabnerLongo2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Tamoxifen is excreted in bile and is eliminated in feces, while small amounts are eliminated in urine.<span class="mw-ref" id="cite_ref-MorelloWurz2003_3-20"><a href="#cite_note-MorelloWurz2003-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Tamoxifen is a nonsteroidal SERM of the triphenylethylene family and was structurally derived from <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>-like estrogens and antiestrogens such as <a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">chlorotrianisene</a> and ethamoxytriphetol.<span class="mw-ref" id="cite_ref-Jordan1986_86-0"><a href="#cite_note-Jordan1986-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-Pratt1994_87-0"><a href="#cite_note-Pratt1994-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span><span class="mw-ref" id="cite_ref-MaximovMcDaniel2013_88-0"><a href="#cite_note-MaximovMcDaniel2013-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-Ravina2011_89-0"><a href="#cite_note-Ravina2011-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> Initially, <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a> was synthesized, and tamoxifen was developed subsequently.<span class="mw-ref" id="cite_ref-Jordan1986_86-1"><a href="#cite_note-Jordan1986-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-MaximovMcDaniel2013_88-1"><a href="#cite_note-MaximovMcDaniel2013-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-Ravina2011_89-1"><a href="#cite_note-Ravina2011-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> Tamoxifen is closely related structurally to other triphenylethylenes, such as clomifene, nafoxidine, ospemifene, <a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">toremifene</a>, and numerous others.<span class="mw-ref" id="cite_ref-CanoAlsina2006_90-0"><a href="#cite_note-CanoAlsina2006-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-OrwollBilezikian2009_91-0"><a href="#cite_note-OrwollBilezikian2009-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> Other SERMs, like <a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">raloxifene</a>, are structurally distinct from tamoxifen and other triphenylethylenes.<span class="mw-ref" id="cite_ref-OrwollBilezikian2009_91-1"><a href="#cite_note-OrwollBilezikian2009-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>In the late 1950s, pharmaceutical companies were actively researching a newly discovered class of anti-estrogen compounds in the hope of developing a morning-after contraceptive pill. Arthur L Walpole was a reproductive endocrinologist who led such a team at the Alderley Park research laboratories of ICI Pharmaceuticals.<span class="mw-ref" id="cite_ref-Jordan_2006_13-1"><a href="#cite_note-Jordan_2006-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It was there in 1962 that chemist Dora Richardson first synthesized tamoxifen, back then known as ICI-46,474, when she was looking to create triphenylethylene derivatives for the contraceptive pill project that her team was researching.<span class="mw-ref" id="cite_ref-isbn0-471-89979-8_92-0"><a href="#cite_note-isbn0-471-89979-8-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>

<p>This compound was originally created to work as an estrogen inhibitor, but instead was found to stimulate ovulation in participants of the drug testing trial.<span class="mw-ref" id="cite_ref-Viviane_M_2017_12-1"><a href="#cite_note-Viviane_M_2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Walpole and his colleagues filed a UK patent covering this compound in 1962, but patent protection on this compound was repeatedly denied in the US until the 1980s.<span class="mw-ref" id="cite_ref-Jordan_2003_93-0"><a href="#cite_note-Jordan_2003-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> Tamoxifen did eventually receive marketing approval as a fertility treatment, but the class of compounds never proved useful in human contraception. A link between estrogen and breast cancer had been known for many years, but cancer treatments were not a corporate priority at the time, and Walpole's personal interests were important in keeping support for the compound alive in the face of this and the lack of patent protection.<span class="mw-ref" id="cite_ref-Jordan_2006_13-2"><a href="#cite_note-Jordan_2006-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It was only when Walpole threatened to leave his position that corporate decided to allow trials and testing for Tamoxifen as a drug that could be used to treat breast cancer. Without Walpole's effort towards defending the work that his team had done in discovering a possibly revolutionary source for breast cancer treatment, Tamoxifen could have become a discarded or under-researched idea. Walpole's team consisted of Dora Richardson and G.A. Snow, who worked on the chemistry portion of the project, along with G.E. Paget and J.K. Walley, who focused primarily on the biological side.<span class="mw-ref" id="cite_ref-Viviane_M_2017_12-2"><a href="#cite_note-Viviane_M_2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Tamoxifen is one of three drugs in an anti-angiogenetic protocol developed by Dr. Judah Folkman, a researcher at Children's Hospital at Harvard Medical School in Boston. Folkman discovered in the 1970s that angiogenesis – the growth of new blood vessels – plays a significant role in the development of cancer. Since his discovery, an entirely new field of cancer research has developed. Clinical trials on angiogenesis inhibitors have been underway since 1992 using many different drugs. The Harvard researchers developed a specific protocol for a golden retriever named Navy who was cancer-free after receiving the prescribed cocktail of <a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">celecoxib</a>, <a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">doxycycline</a>, and tamoxifen – the treatment subsequently became known as the Navy Protocol.<span class="mw-ref" id="cite_ref-urlUSA_Today_94-0"><a href="#cite_note-urlUSA_Today-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> Furthermore, tamoxifen treatment alone has been shown to have anti-angiogenetic effects in animal models of cancer which appear to be, at least in part, independent of tamoxifen's ER antagonist properties.<span class="mw-ref" id="cite_ref-pmid11106254_95-0"><a href="#cite_note-pmid11106254-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span></p>

<p>Other antiestrogens, such as ethamoxytriphetol (MER-25) and <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a> (MRL-41), were assessed for treatment of breast cancer and found to be effective before tamoxifen, but were plagued with toxicity issues.<span class="mw-ref" id="cite_ref-pmid12796359_96-0"><a href="#cite_note-pmid12796359-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-HowellJordan2013_97-0"><a href="#cite_note-HowellJordan2013-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> The first clinical study of tamoxifen took place at the Christie Hospital in 1971, and showed a convincing effect in advanced breast cancer, but nevertheless ICI's development programme came close to termination when it was reviewed in 1972.<span class="mw-ref" id="cite_ref-Cole_1971_98-0"><a href="#cite_note-Cole_1971-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> In an unpublished article from the early days of the trial, Dora Richardson documented her team's excitement about tamoxifen's effects in counteracting infertility problems and the early positive effects found in breast cancer patients. Unfortunately, this work was not well received by everyone, as the team was supposed to be looking for a contraceptive pill.<span class="mw-ref" id="cite_ref-Viviane_M_2017_12-3"><a href="#cite_note-Viviane_M_2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Tamoxifen's further development may have been bolstered by a second clinical study by Harold W.C. Ward <span class="mw-ref" id="cite_ref-Ward_1973_99-0"><a href="#cite_note-Ward_1973-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> at the Queen Elizabeth Hospital, Birmingham. Ward's study showed a more definitive response to the drug at a higher dosage. Walpole also may have helped to convince the company to market tamoxifen for late stage breast cancer in 1973.<span class="mw-ref" id="cite_ref-Jordan_2003_93-1"><a href="#cite_note-Jordan_2003-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> He was also instrumental in funding V. Craig Jordan to work on tamoxifen. In 1972, ICI Pharmaceuticals Division abandoned development of tamoxifen for financial reasons. The drug was subsequently reinvented from a failed contraceptive, to become tamoxifen, the gold standard for the adjuvant treatment of breast cancer and the pioneering medicine for chemprevention for high risk women.<span class="mw-ref" id="cite_ref-100"><a href="#cite_note-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span><span class="mw-ref" id="cite_ref-101"><a href="#cite_note-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> Two books, <i>Estrogen Action, Selective Estrogen Receptor Modulators and Women's Health</i> (Imperial College Press 2013) and <i>Tamoxifen Pioneering Medicine in Breast Cancer</i> (Springer 2013) tell this story.</p>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="font-size:small; margin: 1em auto;">
<caption class="nowrap"> <span style="font-family:sans-serif;font-size:105%;color:black;background-color:transparent;;">Comparison of early clinical experience with antiestrogens for advanced breast cancer</span></caption>
<tbody><tr><th>Antiestrogen</th>
<th>Dosage</th>
<th>Year(s)</th>
<th>Response rate</th>
<th>Toxicity</th></tr>
<tr>
<td>Ethamoxytriphetol</td>
<td>500–4,500 mg/day</td>
<td>1960</td>
<td>25%</td>
<td>Acute psychotic episodes</td></tr>
<tr>
<td><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></td>
<td>100–300 mg/day</td>
<td>1964–1974</td>
<td>34%</td>
<td>Fears of cataracts</td></tr>
<tr>
<td>Nafoxidine</td>
<td>180–240 mg/day</td>
<td>1976</td>
<td>31%</td>
<td>Cataracts, ichthyosis, photophobia</td></tr>
<tr>
<td>Tamoxifen</td>
<td>20–40 mg/day</td>
<td>1971–1973</td>
<td>31%</td>
<td>Transient thrombocytopenia<sup>a</sup></td></tr>
<tr>
<td colspan="5" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = "The particular advantage of this drug is the low incidence of troublesome side effects (25)." "Side effects were usually trivial (26)." <b>Sources:</b> See template.</td></tr>
</tbody></table>

<p>1980 saw the publication of the first trial to show that tamoxifen given in addition to chemotherapy improved survival for patients with early breast cancer.<span class="mw-ref" id="cite_ref-Baum_2003_102-0"><a href="#cite_note-Baum_2003-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> In advanced disease, tamoxifen is now only recognized as effective in ER+ patients, but the early trials did not select ER+ patients, and by the mid 1980s the clinical trial picture was not showing a major advantage for tamoxifen.<span class="mw-ref" id="cite_ref-FURR_1984_103-0"><a href="#cite_note-FURR_1984-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> Nevertheless, tamoxifen had a relatively mild side-effect profile, and a number of large trials continued.</p>

<p>The pharmacology of SERMs was discovered, defined, and deciphered during the 1980s <span class="mw-ref" id="cite_ref-104"><a href="#cite_note-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span> A clinical strategy was described <span class="mw-ref" id="cite_ref-105"><a href="#cite_note-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> that led to the creation of SERMs as a group of multifunctional medicines aimed at the treatment or prevention of many conditions in postmenopausal women, e.g. osteoporosis and breast cancer. This story is told in: V. Craig Jordan, ed. 2013. "Estrogen Action, Selective Estrogen Receptor Modulators and Women's Health" Imperial College Press, Singapore.</p>

<p>The early sales of tamoxifen in both the UK and in the U.S. far exceeded ICI's original estimate, but despite this, at the annual portfolio review ICI's board members still asserted that "there was no market for cancer", leaving the drug's marketing success to rely on its clinical results and clinicians and scientists interests in it. Shortly after, Dora Richardson published a history of Tamoxifen that, unusually for that type of paper, included personal accounts and letters from patients who attributed their healing to the drug. It is by giving voice to cancer patients using Tamoxifen, and so helping to push it forward, by justifying it both morally and scientifically to corporations.<span class="mw-ref" id="cite_ref-Viviane_M_2017_12-4"><a href="#cite_note-Viviane_M_2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>It was not until 1998 that the meta-analysis of the Oxford-based Early Breast Cancer Trialists' Collaborative Group showed definitively that tamoxifen saved lives in early breast cancer.<span class="mw-ref" id="cite_ref-pmid9605801_106-0"><a href="#cite_note-pmid9605801-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Tamoxifen is marketed primarily under the brand name Nolvadex, but is also available under a variety of other brand names throughout the world.<span class="mw-ref" id="cite_ref-Drugs.com_107-0"><a href="#cite_note-Drugs.com-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Economics">Economics</h3></summary>
    
<p>Global sales of tamoxifen in 2001 were $1,024 million.<span class="mw-ref" id="cite_ref-urlCancer_the_generic_impact_108-0"><a href="#cite_note-urlCancer_the_generic_impact-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span> Since the expiration of the patent in 2002, it is widely available as a generic drug around the world. <span>As of 2004</span>, tamoxifen was the world's largest selling hormonal drug for the treatment of breast cancer.<span class="mw-ref" id="cite_ref-urlwww.astrazeneca.se_109-0"><a href="#cite_note-urlwww.astrazeneca.se-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>In McCune-Albright syndrome (MAS) tamoxifen has been used to treat premature puberty and the consequences of premature puberty. Tamoxifen has been seen to decrease rapid bone maturation which is the result of excessive estrogen and alter predicted adult height (PAH).<span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span><span class="mw-ref" id="cite_ref-111"><a href="#cite_note-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span> The same effects have also been seen in short pubertal boys.<span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span> However, one <i>in vitro</i> study in 2007 and later an <i>in vivo</i> study in 2008 have shown that tamoxifen induces apoptosis in growth plate chondrocytes, reduces serum insulin-like growth factor 1 (IGF-1) levels and causes persistent retardation of longitudinal and cortical radial bone growth in young male rats, leading the researchers to express concern giving tamoxifen to growing individuals.<span class="mw-ref" id="cite_ref-pmid18348701_113-0"><a href="#cite_note-pmid18348701-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span><span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span></p>

<p>Tamoxifen has been studied in the treatment of the rare conditions of retroperitoneal fibrosis<span class="mw-ref" id="cite_ref-pmid16418409_115-0"><a href="#cite_note-pmid16418409-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span> and idiopathic sclerosing mesenteritis.<span class="mw-ref" id="cite_ref-pmid17478346_116-0"><a href="#cite_note-pmid17478346-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span> It has also been proposed as part of a treatment plan for Riedel's thyroiditis.<span class="mw-ref" id="cite_ref-pmid12698518_117-0"><a href="#cite_note-pmid12698518-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span></p>

<p>Tamoxifen is used as a research tool to trigger tissue-specific gene expression in many conditional expression constructs in genetically modified animals including a version of the Cre-Lox recombination technique.<span class="mw-ref" id="cite_ref-pmid8855277_118-0"><a href="#cite_note-pmid8855277-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span></p>

<p>Tamoxifen may be effective in the treatment of mania in people with bipolar disorder.<span class="mw-ref" id="cite_ref-TalaeiPourgholami2016_119-0"><a href="#cite_note-TalaeiPourgholami2016-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> This is thought to be due to blockade of protein kinase C (PKC), an enzyme that regulates neuron activity in the brain.<span class="mw-ref" id="cite_ref-TalaeiPourgholami2016_119-1"><a href="#cite_note-TalaeiPourgholami2016-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span><span class="mw-ref" id="cite_ref-SaxenaScaini2017_120-0"><a href="#cite_note-SaxenaScaini2017-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span> Researchers believe PKC is overactive during the mania in bipolar patients.<span class="mw-ref" id="cite_ref-TalaeiPourgholami2016_119-2"><a href="#cite_note-TalaeiPourgholami2016-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span><span class="mw-ref" id="cite_ref-SaxenaScaini2017_120-1"><a href="#cite_note-SaxenaScaini2017-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span> <span>As of September 2019</span>, endoxifen, a major active metabolite of tamoxifen with a fourfold more potent PKC inhibition, was in phase III clinical trials for bipolar disorder.<span class="mw-ref" id="cite_ref-AdisInsight-Endoxifen_121-0"><a href="#cite_note-AdisInsight-Endoxifen-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span><span class="mw-ref" id="cite_ref-pmid29207335_122-0"><a href="#cite_note-pmid29207335-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=42901  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=42901'" tppabs="http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=42901" class="external text external">"NCI Drug Dictionary"</a>. 2011-02-02. <a href="javascript:if(confirm('https://web.archive.org/web/20151208154459/http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=42901  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151208154459/http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=42901'" tppabs="https://web.archive.org/web/20151208154459/http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=42901" class="external text external">Archived</a> from the original on 8 December 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">28 November</span> 2015</span>.</cite></span></li><li id="cite_note-Drugs.com_pregnancy-2"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/tamoxifen.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/tamoxifen.html'" tppabs="https://www.drugs.com/pregnancy/tamoxifen.html" class="external text external">"Tamoxifen Use During Pregnancy"</a>. <i>Drugs.com</i>. 25 July 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">27 January</span> 2020</span>.</cite></span></li><li id="cite_note-MorelloWurz2003-3"> <span id="mw-reference-text-cite_note-MorelloWurz2003-3" class="mw-reference-text"><cite id="CITEREFMorelloWurzDeGregorio2003" class="citation journal cs1">Morello KC, Wurz GT, DeGregorio MW (2003). "Pharmacokinetics of selective estrogen receptor modulators". <i>Clinical Pharmacokinetics</i>. <b>42</b> (4): 361–72. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200342040-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200342040-00004'" tppabs="https://doi.org/10.2165%2F00003088-200342040-00004" class="external text external">10.2165/00003088-200342040-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12648026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12648026'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12648026" class="external text external">12648026</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:13003168  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:13003168'" tppabs="https://api.semanticscholar.org/CorpusID:13003168" class="external text external">13003168</a>.</cite></span></li><li id="cite_note-BrennerStevens2017-4"> <span id="mw-reference-text-cite_note-BrennerStevens2017-4" class="mw-reference-text"><cite id="CITEREFGeorge_M._BrennerCraig_Stevens2017" class="citation book cs1">George M. Brenner; Craig Stevens (28 September 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=v3g4DwAAQBAJ&pg=PA394  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=v3g4DwAAQBAJ&pg=PA394'" tppabs="https://books.google.com/books?id=v3g4DwAAQBAJ&pg=PA394" class="external text external"><i>Brenner and Stevens' Pharmacology E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>394–. ISBN<span>&nbsp;</span><bdi>978-0-323-39172-6</bdi>.</cite></span></li><li id="cite_note-ChabnerLongo2011-5"> <span id="mw-reference-text-cite_note-ChabnerLongo2011-5" class="mw-reference-text"><cite id="CITEREFBruce_A._ChabnerDan_L._Longo2011" class="citation book cs1">Bruce A. Chabner; Dan L. Longo (7 December 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=0U4aj4GZWCIC&pg=PA655  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0U4aj4GZWCIC&pg=PA655'" tppabs="https://books.google.com/books?id=0U4aj4GZWCIC&pg=PA655" class="external text external"><i>Cancer Chemotherapy and Biotherapy: Principles and Practice</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>655–. ISBN<span>&nbsp;</span><bdi>978-1-4511-4820-6</bdi>.</cite></span></li><li id="cite_note-Nolvadex-Label-6"> <span id="mw-reference-text-cite_note-Nolvadex-Label-6" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf" class="external free external">https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf</a></span></li><li id="cite_note-Sanchez-SpitmanSwen2019-7"> <span id="mw-reference-text-cite_note-Sanchez-SpitmanSwen2019-7" class="mw-reference-text"><cite id="CITEREFSanchez-SpitmanSwenDezentjeMoes2019" class="citation journal cs1">Sanchez-Spitman AB, Swen JJ, Dezentje VO, Moes DJ, Gelderblom H, Guchelaar HJ (June 2019). <a href="javascript:if(confirm('https://doi.org/10.1080/17512433.2019.1610390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080/17512433.2019.1610390'" tppabs="https://doi.org/10.1080/17512433.2019.1610390" class="external text external">"Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen"</a>. <i>Expert Review of Clinical Pharmacology</i>. <b>12</b> (6): 523–536. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1080%2F17512433.2019.1610390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F17512433.2019.1610390'" tppabs="https://doi.org/10.1080%2F17512433.2019.1610390" class="external text external">10.1080/17512433.2019.1610390</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31008668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31008668'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31008668" class="external text external">31008668</a>.</cite></span></li><li id="cite_note-NCI2015-8"> <span id="mw-reference-text-cite_note-NCI2015-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate'" tppabs="http://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate" class="external text external">"Tamoxifen Citrate"</a>. <i>NCI</i>. August 26, 2015. <a href="javascript:if(confirm('https://web.archive.org/web/20160104184533/http://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160104184533/http://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate'" tppabs="https://web.archive.org/web/20160104184533/http://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate" class="external text external">Archived</a> from the original on 4 January 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">28 November</span> 2015</span>.</cite></span></li><li id="cite_note-AHFS2015-9"> <span id="mw-reference-text-cite_note-AHFS2015-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/tamoxifen-citrate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/tamoxifen-citrate.html'" tppabs="https://www.drugs.com/monograph/tamoxifen-citrate.html" class="external text external">"Tamoxifen Citrate"</a>. <i>The American Society of Health-System Pharmacists</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20140104090258/http://www.drugs.com/monograph/tamoxifen-citrate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140104090258/http://www.drugs.com/monograph/tamoxifen-citrate.html'" tppabs="https://web.archive.org/web/20140104090258/http://www.drugs.com/monograph/tamoxifen-citrate.html" class="external text external">Archived</a> from the original on 2014-01-04<span class="reference-accessdate">. Retrieved <span class="nowrap">27 Nov</span> 2015</span>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/drug-class/selective-estrogen-receptor-modulators.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/drug-class/selective-estrogen-receptor-modulators.html'" tppabs="https://www.drugs.com/drug-class/selective-estrogen-receptor-modulators.html" class="external text external">"Selective estrogen receptor modulators"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20131209195629/http://www.drugs.com/drug-class/selective-estrogen-receptor-modulators.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131209195629/http://www.drugs.com/drug-class/selective-estrogen-receptor-modulators.html'" tppabs="https://web.archive.org/web/20131209195629/http://www.drugs.com/drug-class/selective-estrogen-receptor-modulators.html" class="external text external">Archived</a> from the original on 9 December 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">28 November</span> 2015</span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFCanoCalaf_i_AlsinaDuenas-Diez2006" class="citation book cs1">Cano A, Calaf i Alsina J, Duenas-Diez JL, eds. (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=heJDAAAAQBAJ&pg=PA52  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=heJDAAAAQBAJ&pg=PA52'" tppabs="https://books.google.com/books?id=heJDAAAAQBAJ&pg=PA52" class="external text external"><i>Selective Estrogen Receptor Modulators a New Brand of Multitarget Drugs</i></a>. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg. p.<span>&nbsp;</span>52. ISBN<span>&nbsp;</span><bdi>9783540347422</bdi>.</cite></span></li><li id="cite_note-Viviane_M_2017-12"> <span id="mw-reference-text-cite_note-Viviane_M_2017-12" class="mw-reference-text"><cite id="CITEREFQuirke2017" class="citation journal cs1">Quirke VM (12 Sep 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600945  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600945'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600945" class="external text external">"Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case-Study in Pharmaceutical Innovation"</a>. <i>Frontiers in Pharmacology</i>. <b>8</b>: 620. doi:<a href="javascript:if(confirm('https://doi.org/10.3389%2Ffphar.2017.00620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3389%2Ffphar.2017.00620'" tppabs="https://doi.org/10.3389%2Ffphar.2017.00620" class="external text external">10.3389/fphar.2017.00620</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600945  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600945'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600945" class="external text external">5600945</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28955226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28955226'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28955226" class="external text external">28955226</a>.</cite></span></li><li id="cite_note-Jordan_2006-13"> <span id="mw-reference-text-cite_note-Jordan_2006-13" class="mw-reference-text"><cite id="CITEREFJordan2006" class="citation journal cs1">Jordan VC (January 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760730'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760730" class="external text external">"Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer"</a>. <i>British Journal of Pharmacology</i>. 147 Suppl 1 (Suppl 1): S269-76. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bjp.0706399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bjp.0706399'" tppabs="https://doi.org/10.1038%2Fsj.bjp.0706399" class="external text external">10.1038/sj.bjp.0706399</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760730'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760730" class="external text external">1760730</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16402113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16402113'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16402113" class="external text external">16402113</a>.</cite></span></li><li id="cite_note-WHO21st-14"> <span id="mw-reference-text-cite_note-WHO21st-14" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/TamoxifenCitrate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/TamoxifenCitrate'" tppabs="https://clincalc.com/DrugStats/Drugs/TamoxifenCitrate" class="external text external">"Tamoxifen Citrate - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-Jordan_1993-17"> <span id="mw-reference-text-cite_note-Jordan_1993-17" class="mw-reference-text"><cite id="CITEREFJordan1993" class="citation journal cs1">Jordan VC (October 1993). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175926  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175926'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175926" class="external text external">"Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer"</a>. <i>British Journal of Pharmacology</i>. <b>110</b> (2): 507–17. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1476-5381.1993.tb13840.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1476-5381.1993.tb13840.x'" tppabs="https://doi.org/10.1111%2Fj.1476-5381.1993.tb13840.x" class="external text external">10.1111/j.1476-5381.1993.tb13840.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175926  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175926'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175926" class="external text external">2175926</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8242225  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8242225'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8242225" class="external text external">8242225</a>.</cite></span></li><li id="cite_note-urlBreast_cancer_in_men:_Cancer_Research_UK:_CancerHelp_UK-18"> <span id="mw-reference-text-cite_note-urlBreast_cancer_in_men:_Cancer_Research_UK:_CancerHelp_UK-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20081201175641/http://www.cancerhelp.org.uk/help/default.asp?page=5075  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081201175641/http://www.cancerhelp.org.uk/help/default.asp?page=5075'" tppabs="https://web.archive.org/web/20081201175641/http://www.cancerhelp.org.uk/help/default.asp?page=5075" class="external text external">"Breast cancer in men"</a>. <i>CancerHelp UK</i>. Cancer Research UK. 2007-09-28. Archived from <a href="javascript:if(confirm('http://www.cancerhelp.org.uk/help/default.asp?page=5075  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancerhelp.org.uk/help/default.asp?page=5075'" tppabs="http://www.cancerhelp.org.uk/help/default.asp?page=5075" class="external text external">the original</a> on 2008-12-01<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-22</span></span>.</cite></span></li><li id="cite_note-FDA-19"> <span id="mw-reference-text-cite_note-FDA-19" class="mw-reference-text"><cite id="CITEREFCenter_for_Drug_Evaluation_and_Research2005" class="citation web cs1">Center for Drug Evaluation and Research (July 7, 2005). <a href="javascript:if(confirm('https://web.archive.org/web/20070619012859/https://www.fda.gov/cder/news/tamoxifen/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070619012859/https://www.fda.gov/cder/news/tamoxifen/'" tppabs="https://web.archive.org/web/20070619012859/https://www.fda.gov/cder/news/tamoxifen/" class="external text external">"Tamoxifen Information: reducing the incidence of breast cancer in women at high risk"</a>. U.S. Food and Drug Administration. Archived from <a href="javascript:if(confirm('https://www.fda.gov/cder/news/tamoxifen/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/cder/news/tamoxifen/'" tppabs="https://www.fda.gov/cder/news/tamoxifen/" class="external text external">the original</a> on June 19, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">July 3,</span> 2007</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFBursteinTeminAndersonBuchholz2014" class="citation journal cs1">Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE,  et al. (July 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310" class="external text external">"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update"</a>. <i>Journal of Clinical Oncology</i>. <b>32</b> (21): 2255–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2013.54.2258  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2013.54.2258'" tppabs="https://doi.org/10.1200%2FJCO.2013.54.2258" class="external text external">10.1200/JCO.2013.54.2258</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310" class="external text external">4876310</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24868023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24868023'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24868023" class="external text external">24868023</a>.</cite></span></li><li id="cite_note-NCI-21"> <span id="mw-reference-text-cite_note-NCI-21" class="mw-reference-text"><cite id="CITEREFNational_Cancer_Institute2006" class="citation web cs1">National Cancer Institute (2006-04-26). <a href="javascript:if(confirm('https://web.archive.org/web/20070704091218/http://www.cancer.gov/star  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070704091218/http://www.cancer.gov/star'" tppabs="https://web.archive.org/web/20070704091218/http://www.cancer.gov/star" class="external text external">"Study of Tamoxifen and Raloxifene (STAR) Trial"</a>. U.S. National Institutes of Health. Archived from <a href="javascript:if(confirm('http://www.cancer.gov/star  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.gov/star'" tppabs="http://www.cancer.gov/star" class="external text external">the original</a> on July 4, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">July 3,</span> 2007</span>.</cite></span></li><li id="cite_note-STAR-22"> <span id="mw-reference-text-cite_note-STAR-22" class="mw-reference-text"><cite id="CITEREFUniversity_of_Pittsburgh" class="citation web cs1">University of Pittsburgh. <a href="javascript:if(confirm('https://web.archive.org/web/20070611194336/http://www.nsabp.pitt.edu/STAR/Index.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070611194336/http://www.nsabp.pitt.edu/STAR/Index.html'" tppabs="https://web.archive.org/web/20070611194336/http://www.nsabp.pitt.edu/STAR/Index.html" class="external text external">"STAR Study of Tamoxifen and Raloxifen"</a>. Archived from <a href="javascript:if(confirm('http://www.nsabp.pitt.edu/STAR/Index.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nsabp.pitt.edu/STAR/Index.html'" tppabs="http://www.nsabp.pitt.edu/STAR/Index.html" class="external text external">the original</a> on June 11, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">July 3,</span> 2007</span>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFDr_Susan_Love2006" class="citation web cs1">Dr Susan Love (April 22, 2006). <a href="javascript:if(confirm('https://web.archive.org/web/20090802013050/http://www.dslrf.org/breastcancer/content.asp?L2=2&L3=6&SID=130&CID=391&PID=14&CATID=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090802013050/http://www.dslrf.org/breastcancer/content.asp?L2=2&L3=6&SID=130&CID=391&PID=14&CATID=0'" tppabs="https://web.archive.org/web/20090802013050/http://www.dslrf.org/breastcancer/content.asp?L2=2&L3=6&SID=130&CID=391&PID=14&CATID=0" class="external text external">"Study Finds New Use for Raloxifene: Reducing Breast Cancer in High-Risk Postmenopausal Women"</a>. Archived from <a href="javascript:if(confirm('http://www.dslrf.org/breastcancer/content.asp?L2=2&L3=6&SID=130&CID=391&PID=14&CATID=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.dslrf.org/breastcancer/content.asp?L2=2&L3=6&SID=130&CID=391&PID=14&CATID=0'" tppabs="http://www.dslrf.org/breastcancer/content.asp?L2=2&L3=6&SID=130&CID=391&PID=14&CATID=0" class="external text external">the original</a> on August 2, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">March 19,</span> 2009</span>.</cite></span></li><li id="cite_note-Steiner_2005-24"> <span id="mw-reference-text-cite_note-Steiner_2005-24" class="mw-reference-text"><cite id="CITEREFSteinerTerplanPaulson2005" class="citation journal cs1">Steiner AZ, Terplan M, Paulson RJ (June 2005). <a href="javascript:if(confirm('https://doi.org/10.1093/humrep/deh840  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/humrep/deh840'" tppabs="https://doi.org/10.1093/humrep/deh840" class="external text external">"Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis"</a>. <i>Human Reproduction</i>. <b>20</b> (6): 1511–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fhumrep%2Fdeh840  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fhumrep%2Fdeh840'" tppabs="https://doi.org/10.1093%2Fhumrep%2Fdeh840" class="external text external">10.1093/humrep/deh840</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15845599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15845599'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15845599" class="external text external">15845599</a>.</cite></span></li><li id="cite_note-pmid23970453-25"> <span id="mw-reference-text-cite_note-pmid23970453-25" class="mw-reference-text"><cite id="CITEREFChuaEscusaLunaTapia2013" class="citation journal cs1">Chua ME, Escusa KG, Luna S, Tapia LC, Dofitas B, Morales M (September 2013). "Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis". <i>Andrology</i>. <b>1</b> (5): 749–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.2047-2927.2013.00107.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.2047-2927.2013.00107.x'" tppabs="https://doi.org/10.1111%2Fj.2047-2927.2013.00107.x" class="external text external">10.1111/j.2047-2927.2013.00107.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23970453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23970453'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23970453" class="external text external">23970453</a>.</cite></span></li><li id="cite_note-Lapidvan_Wingerden2013-26"> <span id="mw-reference-text-cite_note-Lapidvan_Wingerden2013-26" class="mw-reference-text"><cite id="CITEREFLapidvan_WingerdenPerlemuter2013" class="citation journal cs1">Lapid O, van Wingerden JJ, Perlemuter L (2013). "Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review". <i>Journal of Pediatric Endocrinology &amp; Metabolism</i>. <b>26</b> (9–10): 803–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2Fjpem-2013-0052  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2Fjpem-2013-0052'" tppabs="https://doi.org/10.1515%2Fjpem-2013-0052" class="external text external">10.1515/jpem-2013-0052</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23729603  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23729603'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23729603" class="external text external">23729603</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:2101602  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:2101602'" tppabs="https://api.semanticscholar.org/CorpusID:2101602" class="external text external">2101602</a>.</cite></span></li><li id="cite_note-VianiBernardes_da_Silva2012-27"> <span id="mw-reference-text-cite_note-VianiBernardes_da_Silva2012-27" class="mw-reference-text"><cite id="CITEREFVianiBernardes_da_SilvaStefano2012" class="citation journal cs1">Viani GA, Bernardes da Silva LG, Stefano EJ (July 2012). "Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?". <i>International Journal of Radiation Oncology, Biology, Physics</i>. <b>83</b> (4): e519-24. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijrobp.2012.01.036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijrobp.2012.01.036'" tppabs="https://doi.org/10.1016%2Fj.ijrobp.2012.01.036" class="external text external">10.1016/j.ijrobp.2012.01.036</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22704706  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22704706'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22704706" class="external text external">22704706</a>.</cite></span></li><li id="cite_note-pmid29322112-28"> <span id="mw-reference-text-cite_note-pmid29322112-28" class="mw-reference-text"><cite id="CITEREFFentiman2018" class="citation journal cs1">Fentiman IS (January 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758064  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758064'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758064" class="external text external">"Managing Male Mammary Maladies"</a>. <i>Eur J Breast Health</i>. <b>14</b> (1): 5–9. doi:<a href="javascript:if(confirm('https://doi.org/10.5152%2Fejbh.2017.3841  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5152%2Fejbh.2017.3841'" tppabs="https://doi.org/10.5152%2Fejbh.2017.3841" class="external text external">10.5152/ejbh.2017.3841</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758064  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758064'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758064" class="external text external">5758064</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29322112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29322112'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29322112" class="external text external">29322112</a>.</cite></span></li><li id="cite_note-pmid-29"> <span id="mw-reference-text-cite_note-pmid-29" class="mw-reference-text"><cite id="CITEREFFradetEgerdieAndersenTammela2007" class="citation journal cs1">Fradet Y, Egerdie B, Andersen M, Tammela TL, Nachabe M, Armstrong J, Morris T, Navani S (July 2007). "Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study". <i>Eur. Urol</i>. <b>52</b> (1): 106–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.eururo.2007.01.031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.eururo.2007.01.031'" tppabs="https://doi.org/10.1016%2Fj.eururo.2007.01.031" class="external text external">10.1016/j.eururo.2007.01.031</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17270340  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17270340'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17270340" class="external text external">17270340</a>.</cite></span></li><li id="cite_note-pmid29292624-30"> <span id="mw-reference-text-cite_note-pmid29292624-30" class="mw-reference-text"><cite id="CITEREFNeymanEugster2017" class="citation journal cs1">Neyman A, Eugster EA (December 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808444'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808444" class="external text external">"Treatment of Girls and Boys with McCune-Albright Syndrome with Precocious Puberty - Update 2017"</a>. <i>Pediatric Endocrinology Reviews</i>. <b>15</b> (2): 136–141. doi:<a href="javascript:if(confirm('https://doi.org/10.17458%2Fper.vol15.2017.nau.treatmentgirlsboys  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.17458%2Fper.vol15.2017.nau.treatmentgirlsboys'" tppabs="https://doi.org/10.17458%2Fper.vol15.2017.nau.treatmentgirlsboys" class="external text external">10.17458/per.vol15.2017.nau.treatmentgirlsboys</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808444'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808444" class="external text external">5808444</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29292624  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29292624'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29292624" class="external text external">29292624</a>.</cite></span></li><li id="cite_note-HaddadEugster2019-31"> <span id="mw-reference-text-cite_note-HaddadEugster2019-31" class="mw-reference-text"><cite id="CITEREFHaddadEugster2019" class="citation journal cs1">Haddad NG, Eugster EA (April 2019). "Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes". <i>Best Practice &amp; Research. Clinical Endocrinology &amp; Metabolism</i>. <b>33</b> (3): 101273. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.beem.2019.04.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.beem.2019.04.007'" tppabs="https://doi.org/10.1016%2Fj.beem.2019.04.007" class="external text external">10.1016/j.beem.2019.04.007</a>. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/1805%2F19111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/1805%2F19111'" tppabs="https://hdl.handle.net/1805%2F19111" class="external text external">1805/19111</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31027974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31027974'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31027974" class="external text external">31027974</a>.</cite></span></li><li id="cite_note-Zacharin2019-32"> <span id="mw-reference-text-cite_note-Zacharin2019-32" class="mw-reference-text"><cite id="CITEREFZacharin2019" class="citation journal cs1">Zacharin M (May 2019). "Disorders of Puberty: Pharmacotherapeutic Strategies for Management". <i>Handbook of Experimental Pharmacology</i>. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F164_2019_208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F164_2019_208'" tppabs="https://doi.org/10.1007%2F164_2019_208" class="external text external">10.1007/164_2019_208</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31144045  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31144045'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31144045" class="external text external">31144045</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text">Product Information: tamoxifen citrate oral tablets, tamoxifen citrate oral tablets. Watson Laboratories (per manufacturer), Corona, CA, 2011.</span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text">Product Information: SOLTAMOX(R) oral solution, tamoxifen citrate oral solution. Midatech Pharma US Inc (per FDA), Raleigh, NC, 2018.</span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFOncoGenetics.Org2009" class="citation web cs1">OncoGenetics.Org (September 2009). <a href="javascript:if(confirm('https://web.archive.org/web/20090924092345/http://www.oncogenetics.org/web/Medications-Effective-in-Reducing-Risk-of-Breast-Cancer-But-Increase-Risk-of-Adverse-Effects  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090924092345/http://www.oncogenetics.org/web/Medications-Effective-in-Reducing-Risk-of-Breast-Cancer-But-Increase-Risk-of-Adverse-Effects'" tppabs="https://web.archive.org/web/20090924092345/http://www.oncogenetics.org/web/Medications-Effective-in-Reducing-Risk-of-Breast-Cancer-But-Increase-Risk-of-Adverse-Effects" class="external text external">"Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects"</a>. OncoGenetics.Org. Archived from <a href="javascript:if(confirm('http://www.oncogenetics.org/web/Medications-Effective-in-Reducing-Risk-of-Breast-Cancer-But-Increase-Risk-of-Adverse-Effects  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.oncogenetics.org/web/Medications-Effective-in-Reducing-Risk-of-Breast-Cancer-But-Increase-Risk-of-Adverse-Effects'" tppabs="http://www.oncogenetics.org/web/Medications-Effective-in-Reducing-Risk-of-Breast-Cancer-But-Increase-Risk-of-Adverse-Effects" class="external text external">the original</a> on September 24, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-09-14</span></span>.</cite></span></li><li id="cite_note-pmid17803905-36"> <span id="mw-reference-text-cite_note-pmid17803905-36" class="mw-reference-text"><cite id="CITEREFNakamuraImaiMatsumotoSato2007" class="citation journal cs1">Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K,  et al. (September 2007). "Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts". <i>Cell</i>. <b>130</b> (5): 811–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.cell.2007.07.025  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.cell.2007.07.025'" tppabs="https://doi.org/10.1016%2Fj.cell.2007.07.025" class="external text external">10.1016/j.cell.2007.07.025</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17803905  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17803905'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17803905" class="external text external">17803905</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:17177462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:17177462'" tppabs="https://api.semanticscholar.org/CorpusID:17177462" class="external text external">17177462</a>.</cite></span></li><li id="cite_note-pmid18219273-37"> <span id="mw-reference-text-cite_note-pmid18219273-37" class="mw-reference-text"><cite id="CITEREFKrumMiranda-CarboniHauschkaCarroll2008" class="citation journal cs1">Krum SA, Miranda-Carboni GA, Hauschka PV, Carroll JS, Lane TF, Freedman LP, Brown M (February 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241656'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241656" class="external text external">"Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival"</a>. <i>The EMBO Journal</i>. <b>27</b> (3): 535–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.emboj.7601984  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.emboj.7601984'" tppabs="https://doi.org/10.1038%2Fsj.emboj.7601984" class="external text external">10.1038/sj.emboj.7601984</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241656'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241656" class="external text external">2241656</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18219273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18219273'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18219273" class="external text external">18219273</a>.</cite></span></li><li id="cite_note-Mincey_2000-38"> <span id="mw-reference-text-cite_note-Mincey_2000-38" class="mw-reference-text"><cite id="CITEREFMinceyMoraghanPerez2000" class="citation journal cs1">Mincey BA, Moraghan TJ, Perez EA (August 2000). <a href="javascript:if(confirm('https://doi.org/10.4065/75.8.821  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065/75.8.821'" tppabs="https://doi.org/10.4065/75.8.821" class="external text external">"Prevention and treatment of osteoporosis in women with breast cancer"</a>. <i>Mayo Clinic Proceedings</i>. <b>75</b> (8): 821–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4065%2F75.8.821  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065%2F75.8.821'" tppabs="https://doi.org/10.4065%2F75.8.821" class="external text external">10.4065/75.8.821</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10943237  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10943237'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10943237" class="external text external">10943237</a>.</cite></span></li><li id="cite_note-pmid16446340-39"> <span id="mw-reference-text-cite_note-pmid16446340-39" class="mw-reference-text"><cite id="CITEREFVehmanenElomaaBlomqvistSaarto2006" class="citation journal cs1">Vehmanen L, Elomaa I, Blomqvist C, Saarto T (February 2006). "Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status". <i>Journal of Clinical Oncology</i>. <b>24</b> (4): 675–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2005.02.3515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2005.02.3515'" tppabs="https://doi.org/10.1200%2FJCO.2005.02.3515" class="external text external">10.1200/JCO.2005.02.3515</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16446340  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16446340'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16446340" class="external text external">16446340</a>.</cite></span></li><li id="cite_note-Gallo_1997-40"> <span id="mw-reference-text-cite_note-Gallo_1997-40" class="mw-reference-text"><cite id="CITEREFGalloKaufman1997" class="citation journal cs1">Gallo MA, Kaufman D (February 1997). "Antagonistic and agonistic effects of tamoxifen: significance in human cancer". <i>Seminars in Oncology</i>. <b>24</b> (1 Suppl 1): S1-71-S1-80. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9045319  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9045319'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9045319" class="external text external">9045319</a>.</cite></span></li><li id="cite_note-Grilli_2006-41"> <span id="mw-reference-text-cite_note-Grilli_2006-41" class="mw-reference-text"><cite id="CITEREFGrilli2006" class="citation journal cs1">Grilli S (2006). <a href="javascript:if(confirm('https://web.archive.org/web/20070810113431/http://www.iss.it/publ/anna/2006/2/422170.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070810113431/http://www.iss.it/publ/anna/2006/2/422170.pdf'" tppabs="https://web.archive.org/web/20070810113431/http://www.iss.it/publ/anna/2006/2/422170.pdf" class="external text external">"Tamoxifen (TAM): the dispute goes on"</a> <span class="cs1-format">(PDF)</span>. <i>Annali dell'Istituto Superiore di Sanita</i>. <b>42</b> (2): 170–3. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17033137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17033137'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17033137" class="external text external">17033137</a>. Archived from <a href="javascript:if(confirm('http://www.iss.it/publ/anna/2006/2/422170.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.iss.it/publ/anna/2006/2/422170.pdf'" tppabs="http://www.iss.it/publ/anna/2006/2/422170.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2007-08-10<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-07-03</span></span>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://healthlifeandstuff.com/2009/12/tamoxifen-for-breast-cancer-side-effects/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://healthlifeandstuff.com/2009/12/tamoxifen-for-breast-cancer-side-effects/'" tppabs="http://healthlifeandstuff.com/2009/12/tamoxifen-for-breast-cancer-side-effects/" class="external text external">"Tamoxifen for Breast Cancer &amp; Side Effects"</a>. Health and Life. 2009-12-11. <a href="javascript:if(confirm('https://web.archive.org/web/20100216232531/http://healthlifeandstuff.com/2009/12/tamoxifen-for-breast-cancer-side-effects/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100216232531/http://healthlifeandstuff.com/2009/12/tamoxifen-for-breast-cancer-side-effects/'" tppabs="https://web.archive.org/web/20100216232531/http://healthlifeandstuff.com/2009/12/tamoxifen-for-breast-cancer-side-effects/" class="external text external">Archived</a> from the original on 2010-02-16.</cite></span></li><li id="cite_note-ACS-43"> <span id="mw-reference-text-cite_note-ACS-43" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cancer.org/docroot/PED/content/PED_1_3x_Known_and_Probable_Carcinogens.asp?sitearea=PED  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.org/docroot/PED/content/PED_1_3x_Known_and_Probable_Carcinogens.asp?sitearea=PED'" tppabs="http://www.cancer.org/docroot/PED/content/PED_1_3x_Known_and_Probable_Carcinogens.asp?sitearea=PED" class="external text external">"Known and Probable Carcinogens"</a>. American Cancer Society. 2006-02-03. <a href="javascript:if(confirm('https://web.archive.org/web/20080317051133/http://www.cancer.org/docroot/PED/content/PED_1_3x_Known_and_Probable_Carcinogens.asp?sitearea=PED  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080317051133/http://www.cancer.org/docroot/PED/content/PED_1_3x_Known_and_Probable_Carcinogens.asp?sitearea=PED'" tppabs="https://web.archive.org/web/20080317051133/http://www.cancer.org/docroot/PED/content/PED_1_3x_Known_and_Probable_Carcinogens.asp?sitearea=PED" class="external text external">Archived</a> from the original on 2008-03-17<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-03-21</span></span>.</cite></span></li><li id="cite_note-pmid16230014-44"> <span id="mw-reference-text-cite_note-pmid16230014-44" class="mw-reference-text"><cite id="CITEREFEstevaHortobagyi2006" class="citation journal cs1">Esteva FJ, Hortobagyi GN (June 2006). "Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women". <i>Breast</i>. <b>15</b> (3): 301–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.breast.2005.08.033  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.breast.2005.08.033'" tppabs="https://doi.org/10.1016%2Fj.breast.2005.08.033" class="external text external">10.1016/j.breast.2005.08.033</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16230014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16230014'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16230014" class="external text external">16230014</a>.</cite></span></li><li id="cite_note-pmid15699284-45"> <span id="mw-reference-text-cite_note-pmid15699284-45" class="mw-reference-text"><cite id="CITEREFDecensiMaisonneuveRotmenszBettega2005" class="citation journal cs1">Decensi A, Maisonneuve P, Rotmensz N, Bettega D, Costa A, Sacchini V,  et al. (February 2005). <a href="javascript:if(confirm('https://doi.org/10.1161/01.CIR.0000154545.84124.AC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/01.CIR.0000154545.84124.AC'" tppabs="https://doi.org/10.1161/01.CIR.0000154545.84124.AC" class="external text external">"Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial"</a>. <i>Circulation</i>. <b>111</b> (5): 650–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2F01.CIR.0000154545.84124.AC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2F01.CIR.0000154545.84124.AC'" tppabs="https://doi.org/10.1161%2F01.CIR.0000154545.84124.AC" class="external text external">10.1161/01.CIR.0000154545.84124.AC</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15699284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15699284'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15699284" class="external text external">15699284</a>.</cite></span></li><li id="cite_note-Harvey_2006-46"> <span id="mw-reference-text-cite_note-Harvey_2006-46" class="mw-reference-text"><cite id="CITEREFHarveyKimuraHajba2006" class="citation journal cs1">Harvey HA, Kimura M, Hajba A (April 2006). "Toremifene: an evaluation of its safety profile". <i>Breast</i>. <b>15</b> (2): 142–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.breast.2005.09.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.breast.2005.09.007'" tppabs="https://doi.org/10.1016%2Fj.breast.2005.09.007" class="external text external">10.1016/j.breast.2005.09.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16289904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16289904'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16289904" class="external text external">16289904</a>.</cite></span></li><li id="cite_note-pmid17181445-47"> <span id="mw-reference-text-cite_note-pmid17181445-47" class="mw-reference-text"><cite id="CITEREFOsmanOsmanAhmed2007" class="citation journal cs1">Osman KA, Osman MM, Ahmed MH (January 2007). "Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?". <i>Expert Opinion on Drug Safety</i>. <b>6</b> (1): 1–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.6.1.1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.6.1.1'" tppabs="https://doi.org/10.1517%2F14740338.6.1.1" class="external text external">10.1517/14740338.6.1.1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17181445  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17181445'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17181445" class="external text external">17181445</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:33505288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:33505288'" tppabs="https://api.semanticscholar.org/CorpusID:33505288" class="external text external">33505288</a>.</cite></span></li><li id="cite_note-pmid11194452-48"> <span id="mw-reference-text-cite_note-pmid11194452-48" class="mw-reference-text"><cite id="CITEREFPaganini-HillClark2000" class="citation journal cs1">Paganini-Hill A, Clark LJ (November 2000). "Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen". <i>Breast Cancer Research and Treatment</i>. <b>64</b> (2): 165–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1023%2FA%3A1006426132338  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1023%2FA%3A1006426132338'" tppabs="https://doi.org/10.1023%2FA%3A1006426132338" class="external text external">10.1023/A:1006426132338</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11194452  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11194452'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11194452" class="external text external">11194452</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:1033695  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:1033695'" tppabs="https://api.semanticscholar.org/CorpusID:1033695" class="external text external">1033695</a>.</cite></span></li><li id="cite_note-pmid14741674-49"> <span id="mw-reference-text-cite_note-pmid14741674-49" class="mw-reference-text"><cite id="CITEREFEberlingWuTong-TurnbeaughJagust2004" class="citation journal cs1">Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ (January 2004). "Estrogen- and tamoxifen-associated effects on brain structure and function". <i>NeuroImage</i>. <b>21</b> (1): 364–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neuroimage.2003.08.037  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neuroimage.2003.08.037'" tppabs="https://doi.org/10.1016%2Fj.neuroimage.2003.08.037" class="external text external">10.1016/j.neuroimage.2003.08.037</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14741674  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14741674'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14741674" class="external text external">14741674</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:15920274  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:15920274'" tppabs="https://api.semanticscholar.org/CorpusID:15920274" class="external text external">15920274</a>.</cite></span></li><li id="cite_note-pmid17898668-50"> <span id="mw-reference-text-cite_note-pmid17898668-50" class="mw-reference-text"><cite id="CITEREFBenderSereikaBrufskyRyan2007" class="citation journal cs1">Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P,  et al. (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831410'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831410" class="external text external">"Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer"</a>. <i>Menopause</i>. <b>14</b> (6): 995–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2Fgme.0b013e318148b28b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2Fgme.0b013e318148b28b'" tppabs="https://doi.org/10.1097%2Fgme.0b013e318148b28b" class="external text external">10.1097/gme.0b013e318148b28b</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831410'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831410" class="external text external">2831410</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17898668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17898668'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17898668" class="external text external">17898668</a>.</cite></span></li><li id="cite_note-pmid10334535-51"> <span id="mw-reference-text-cite_note-pmid10334535-51" class="mw-reference-text"><cite id="CITEREFMortimerBoucherBatyKnapp1999" class="citation journal cs1">Mortimer JE, Boucher L, Baty J, Knapp DL, Ryan E, Rowland JH (May 1999). "Effect of tamoxifen on sexual functioning in patients with breast cancer". <i>Journal of Clinical Oncology</i>. <b>17</b> (5): 1488–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.1999.17.5.1488  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.1999.17.5.1488'" tppabs="https://doi.org/10.1200%2FJCO.1999.17.5.1488" class="external text external">10.1200/JCO.1999.17.5.1488</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10334535  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10334535'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10334535" class="external text external">10334535</a>.</cite></span></li><li id="cite_note-pmid16944295-52"> <span id="mw-reference-text-cite_note-pmid16944295-52" class="mw-reference-text"><cite id="CITEREFCellaFallowfieldBarkerCuzick2006" class="citation journal cs1">Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A (December 2006). "Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer". <i>Breast Cancer Research and Treatment</i>. <b>100</b> (3): 273–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10549-006-9260-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10549-006-9260-6'" tppabs="https://doi.org/10.1007%2Fs10549-006-9260-6" class="external text external">10.1007/s10549-006-9260-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16944295  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16944295'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16944295" class="external text external">16944295</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:24855843  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:24855843'" tppabs="https://api.semanticscholar.org/CorpusID:24855843" class="external text external">24855843</a>.</cite></span></li><li id="cite_note-CameronFeuer2012-53"> <span id="mw-reference-text-cite_note-CameronFeuer2012-53" class="mw-reference-text"><cite id="CITEREFRoss_CameronGeorge_FeuerFelix_de_la_Iglesia2012" class="citation book cs1">Ross Cameron; George Feuer; Felix de la Iglesia (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=xZf-CAAAQBAJ&pg=PA565  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=xZf-CAAAQBAJ&pg=PA565'" tppabs="https://books.google.com/books?id=xZf-CAAAQBAJ&pg=PA565" class="external text external"><i>Drug-Induced Hepatotoxicity</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>565–. ISBN<span>&nbsp;</span><bdi>978-3-642-61013-4</bdi>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.breastcancercare.org.uk/information-support/facing-breast-cancer/going-through-treatment-breast-cancer/hormone-therapy/tamoxifen  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.breastcancercare.org.uk/information-support/facing-breast-cancer/going-through-treatment-breast-cancer/hormone-therapy/tamoxifen'" tppabs="https://www.breastcancercare.org.uk/information-support/facing-breast-cancer/going-through-treatment-breast-cancer/hormone-therapy/tamoxifen" class="external text external">"Tamoxifen: Hormone therapy drugs"</a>. <i>Breast Cancer Care</i>. 2015-06-08<span class="reference-accessdate">. Retrieved <span class="nowrap">2019-09-20</span></span>.</cite></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFKumarAllenCantorCox1997" class="citation journal cs1">Kumar, N.B.; Allen, K.; Cantor, A.; Cox, C.E.; Greenberg, H.; Shah, S.; Lyman, G.H. (1997-06-01). "Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?". <i>Breast Cancer Research and Treatment</i>. <b>44</b> (2): 135–143. doi:<a href="javascript:if(confirm('https://doi.org/10.1023%2FA%3A1005721720840  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1023%2FA%3A1005721720840'" tppabs="https://doi.org/10.1023%2FA%3A1005721720840" class="external text external">10.1023/A:1005721720840</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1573-7217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1573-7217'" tppabs="https://www.worldcat.org/issn/1573-7217" class="external text external">1573-7217</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9232272  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9232272'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9232272" class="external text external">9232272</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:39451228  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:39451228'" tppabs="https://api.semanticscholar.org/CorpusID:39451228" class="external text external">39451228</a>.</cite></span></li><li id="cite_note-Goetz_2005-56"> <span id="mw-reference-text-cite_note-Goetz_2005-56" class="mw-reference-text"><cite id="CITEREFGoetzRaeSumanSafgren2005" class="citation journal cs1">Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW,  et al. (December 2005). "Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes". <i>Journal of Clinical Oncology</i>. <b>23</b> (36): 9312–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2005.03.3266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2005.03.3266'" tppabs="https://doi.org/10.1200%2FJCO.2005.03.3266" class="external text external">10.1200/JCO.2005.03.3266</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16361630  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16361630'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16361630" class="external text external">16361630</a>.</cite></span></li><li id="cite_note-Beverage_2007-57"> <span id="mw-reference-text-cite_note-Beverage_2007-57" class="mw-reference-text"><cite id="CITEREFBeverageSissungSionDanesi2007" class="citation journal cs1">Beverage JN, Sissung TM, Sion AM, Danesi R, Figg WD (September 2007). "CYP2D6 polymorphisms and the impact on tamoxifen therapy". <i>Journal of Pharmaceutical Sciences</i>. <b>96</b> (9): 2224–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjps.20892  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjps.20892'" tppabs="https://doi.org/10.1002%2Fjps.20892" class="external text external">10.1002/jps.20892</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17518364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17518364'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17518364" class="external text external">17518364</a>.</cite></span></li><li id="cite_note-58"> <span id="mw-reference-text-cite_note-58" class="mw-reference-text"><a href="javascript:if(confirm('http://talk.dnadirect.com/2006/10/19/genetic-test-for-response-to-tamoxifen/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://talk.dnadirect.com/2006/10/19/genetic-test-for-response-to-tamoxifen/'" tppabs="http://talk.dnadirect.com/2006/10/19/genetic-test-for-response-to-tamoxifen/" class="external text external">Information about CYP2D6 and tamoxifen from DNADirect's website</a> <a href="javascript:if(confirm('https://web.archive.org/web/20070311134122/http://talk.dnadirect.com/2006/10/19/genetic-test-for-response-to-tamoxifen/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070311134122/http://talk.dnadirect.com/2006/10/19/genetic-test-for-response-to-tamoxifen/'" tppabs="https://web.archive.org/web/20070311134122/http://talk.dnadirect.com/2006/10/19/genetic-test-for-response-to-tamoxifen/" class="external text external">Archived</a><span> 2007-03-11 at the </span>Wayback Machine</span></li><li id="cite_note-pmid19809024-59"> <span id="mw-reference-text-cite_note-pmid19809024-59" class="mw-reference-text"><cite id="CITEREFSchrothGoetzHamannFasching2009" class="citation journal cs1">Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S,  et al. (October 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909953'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909953" class="external text external">"Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen"</a>. <i>JAMA</i>. <b>302</b> (13): 1429–36. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2009.1420  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2009.1420'" tppabs="https://doi.org/10.1001%2Fjama.2009.1420" class="external text external">10.1001/jama.2009.1420</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909953'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909953" class="external text external">3909953</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19809024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19809024'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19809024" class="external text external">19809024</a>.</cite></span></li><li id="cite_note-Jin_2005-60"> <span id="mw-reference-text-cite_note-Jin_2005-60" class="mw-reference-text"><cite id="CITEREFJinDestaStearnsWard2005" class="citation journal cs1">Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH,  et al. (January 2005). <a href="javascript:if(confirm('https://doi.org/10.1093/jnci/dji005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jnci/dji005'" tppabs="https://doi.org/10.1093/jnci/dji005" class="external text external">"CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment"</a>. <i>Journal of the National Cancer Institute</i>. <b>97</b> (1): 30–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjnci%2Fdji005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjnci%2Fdji005'" tppabs="https://doi.org/10.1093%2Fjnci%2Fdji005" class="external text external">10.1093/jnci/dji005</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15632378  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15632378'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15632378" class="external text external">15632378</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFStaff_Reports2009" class="citation news cs1">Staff Reports (Summer 2009). <a href="javascript:if(confirm('http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1152  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1152'" tppabs="http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1152" class="external text external">"ASCO Updates: Antidepressants Reduce the Effectiveness of Tamoxifen"</a>. CURE (Cancer Updates, Research and Education). <a href="javascript:if(confirm('https://web.archive.org/web/20090622192239/http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1152  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090622192239/http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1152'" tppabs="https://web.archive.org/web/20090622192239/http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1152" class="external text external">Archived</a> from the original on 2009-06-22.</cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><cite id="CITEREFKellyJuurlinkGomesDuong-Hua2010" class="citation journal cs1">Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, Paszat LF (February 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817754'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817754" class="external text external">"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study"</a>. <i>BMJ</i>. <b>340</b>: c693. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.c693  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.c693'" tppabs="https://doi.org/10.1136%2Fbmj.c693" class="external text external">10.1136/bmj.c693</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817754'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817754" class="external text external">2817754</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20142325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20142325'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20142325" class="external text external">20142325</a>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><a href="javascript:if(confirm('http://www.tamoxitest.com/what_is_tamoxitest.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.tamoxitest.com/what_is_tamoxitest.html'" tppabs="http://www.tamoxitest.com/what_is_tamoxitest.html" class="external text external">Information about Tamoxitest and how DNA testing can help in the selection of the best treatment methodology from Genelex's website</a> <a href="javascript:if(confirm('https://web.archive.org/web/20100527152154/http://www.tamoxitest.com/what_is_tamoxitest.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100527152154/http://www.tamoxitest.com/what_is_tamoxitest.html'" tppabs="https://web.archive.org/web/20100527152154/http://www.tamoxitest.com/what_is_tamoxitest.html" class="external text external">Archived</a><span> 2010-05-27 at the </span>Wayback Machine</span></li><li id="cite_note-pmid21552410-64"> <span id="mw-reference-text-cite_note-pmid21552410-64" class="mw-reference-text"><cite id="CITEREFCriscitielloFumagalliSainiLoi2010" class="citation journal cs1">Criscitiello C, Fumagalli D, Saini KS, Loi S (December 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084302  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084302'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084302" class="external text external">"Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection"</a>. <i>OncoTargets and Therapy</i>. <b>4</b>: 1–11. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FOTT.S10155  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FOTT.S10155'" tppabs="https://doi.org/10.2147%2FOTT.S10155" class="external text external">10.2147/OTT.S10155</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084302  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084302'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084302" class="external text external">3084302</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21552410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21552410'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21552410" class="external text external">21552410</a>.</cite></span></li><li id="cite_note-pmid9875847-65"> <span id="mw-reference-text-cite_note-pmid9875847-65" class="mw-reference-text"><span class="">PDB: <a href="javascript:if(confirm('https://www.rcsb.org/structure/3ERT  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/3ERT'" tppabs="https://www.rcsb.org/structure/3ERT" class="external text external">3ERT</a></span><span>​</span>; <cite id="CITEREFShiauBarstadLoriaCheng1998" class="citation journal cs1">Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (December 1998). "The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen". <i>Cell</i>. <b>95</b> (7): 927–37. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0092-8674%2800%2981717-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0092-8674%2800%2981717-1'" tppabs="https://doi.org/10.1016%2FS0092-8674%2800%2981717-1" class="external text external">10.1016/S0092-8674(00)81717-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9875847  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9875847'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9875847" class="external text external">9875847</a>.</cite></span></li><li id="cite_note-Wang_2004-66"> <span id="mw-reference-text-cite_note-Wang_2004-66" class="mw-reference-text"><cite id="CITEREFWangFulthorpeLissEdwards2004" class="citation journal cs1">Wang DY, Fulthorpe R, Liss SN, Edwards EA (February 2004). <a href="javascript:if(confirm('https://doi.org/10.1210/me.2003-0202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/me.2003-0202'" tppabs="https://doi.org/10.1210/me.2003-0202" class="external text external">"Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1"</a>. <i>Molecular Endocrinology</i>. <b>18</b> (2): 402–11. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fme.2003-0202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fme.2003-0202'" tppabs="https://doi.org/10.1210%2Fme.2003-0202" class="external text external">10.1210/me.2003-0202</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14605097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14605097'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14605097" class="external text external">14605097</a>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite id="CITEREFAhmadShahabuddinSheikhKale2010" class="citation journal cs1">Ahmad A, Shahabuddin S, Sheikh S, Kale P, Krishnappa M, Rane RC, Ahmad I (December 2010). "Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects". <i>Clinical Pharmacology and Therapeutics</i>. <b>88</b> (6): 814–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fclpt.2010.196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fclpt.2010.196'" tppabs="https://doi.org/10.1038%2Fclpt.2010.196" class="external text external">10.1038/clpt.2010.196</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20981001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20981001'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20981001" class="external text external">20981001</a>.</cite></span></li><li id="cite_note-pmid16112947-68"> <span id="mw-reference-text-cite_note-pmid16112947-68" class="mw-reference-text"><cite id="CITEREFKuhl2005" class="citation journal cs1">Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration". <i>Climacteric</i>. 8 Suppl 1: 3–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500148875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500148875'" tppabs="https://doi.org/10.1080%2F13697130500148875" class="external text external">10.1080/13697130500148875</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16112947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16112947'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16112947" class="external text external">16112947</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:24616324  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:24616324'" tppabs="https://api.semanticscholar.org/CorpusID:24616324" class="external text external">24616324</a>.</cite></span></li><li id="cite_note-pmid15863530-69"> <span id="mw-reference-text-cite_note-pmid15863530-69" class="mw-reference-text"><cite id="CITEREFPottsLobo2005" class="citation journal cs1">Potts RO, Lobo RA (May 2005). "Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist". <i>Obstet Gynecol</i>. <b>105</b> (5 Pt 1): 953–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.AOG.0000161958.70059.db  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.AOG.0000161958.70059.db'" tppabs="https://doi.org/10.1097%2F01.AOG.0000161958.70059.db" class="external text external">10.1097/01.AOG.0000161958.70059.db</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15863530  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15863530'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15863530" class="external text external">15863530</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:23411589  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:23411589'" tppabs="https://api.semanticscholar.org/CorpusID:23411589" class="external text external">23411589</a>.</cite></span></li><li id="cite_note-RunnebaumRabe2013-70"> <span id="mw-reference-text-cite_note-RunnebaumRabe2013-70" class="mw-reference-text"><cite id="CITEREFBenno_RunnebaumThomas_Rabe2013" class="citation book cs1">Benno Runnebaum; Thomas Rabe (17 April 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=mBF9BwAAQBAJ&pg=PA88  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=mBF9BwAAQBAJ&pg=PA88'" tppabs="https://books.google.com/books?id=mBF9BwAAQBAJ&pg=PA88" class="external text external"><i>Gynäkologische Endokrinologie und Fortpflanzungsmedizin: Band 1: Gynäkologische Endokrinologie</i></a>. Springer-Verlag. pp.<span>&nbsp;</span>88–. ISBN<span>&nbsp;</span><bdi>978-3-662-07635-4</bdi>.</cite></span></li><li id="cite_note-WallachHammond1982-71"> <span id="mw-reference-text-cite_note-WallachHammond1982-71" class="mw-reference-text"><cite id="CITEREFWallachHammondMaxson1982" class="citation journal cs1">Wallach, Edward E.; Hammond, Charles B.; Maxson, Wayne S. (1982). "Current status of estrogen therapy for the menopause". <i>Fertility and Sterility</i>. <b>37</b> (1): 5–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0015-0282%2816%2945970-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0015-0282%2816%2945970-4'" tppabs="https://doi.org/10.1016%2FS0015-0282%2816%2945970-4" class="external text external">10.1016/S0015-0282(16)45970-4</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0015-0282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0015-0282'" tppabs="https://www.worldcat.org/issn/0015-0282" class="external text external">0015-0282</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6277697  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6277697'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6277697" class="external text external">6277697</a>.</cite></span></li><li id="cite_note-pmid11136970-72"> <span id="mw-reference-text-cite_note-pmid11136970-72" class="mw-reference-text"><cite id="CITEREFShangHuDiRenzoLazar2000" class="citation journal cs1">Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M (December 2000). "Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription". <i>Cell</i>. <b>103</b> (6): 843–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0092-8674%2800%2900188-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0092-8674%2800%2900188-4'" tppabs="https://doi.org/10.1016%2FS0092-8674%2800%2900188-4" class="external text external">10.1016/S0092-8674(00)00188-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11136970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11136970'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11136970" class="external text external">11136970</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:6659079  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:6659079'" tppabs="https://api.semanticscholar.org/CorpusID:6659079" class="external text external">6659079</a>.</cite></span></li><li id="cite_note-pmid18245484-73"> <span id="mw-reference-text-cite_note-pmid18245484-73" class="mw-reference-text"><cite id="CITEREFMassarwehOsborneCreightonQin2008" class="citation journal cs1">Massarweh S, Osborne CK, Creighton CJ, Qin L, Tsimelzon A, Huang S,  et al. (February 2008). <a href="javascript:if(confirm('https://doi.org/10.1158/0008-5472.CAN-07-2707  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158/0008-5472.CAN-07-2707'" tppabs="https://doi.org/10.1158/0008-5472.CAN-07-2707" class="external text external">"Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function"</a>. <i>Cancer Research</i>. <b>68</b> (3): 826–33. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F0008-5472.CAN-07-2707  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F0008-5472.CAN-07-2707'" tppabs="https://doi.org/10.1158%2F0008-5472.CAN-07-2707" class="external text external">10.1158/0008-5472.CAN-07-2707</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18245484  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18245484'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18245484" class="external text external">18245484</a>.</cite></span></li><li id="cite_note-Hurtado_2008-74"> <span id="mw-reference-text-cite_note-Hurtado_2008-74" class="mw-reference-text"><cite id="CITEREFHurtadoHolmesGeistlingerHutcheson2008" class="citation journal cs1">Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M,  et al. (December 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920208'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920208" class="external text external">"Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen"</a>. <i>Nature</i>. <b>456</b> (7222): 663–6. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2008Natur.456..663H  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2008Natur.456..663H'" tppabs="https://ui.adsabs.harvard.edu/abs/2008Natur.456..663H" class="external text external">2008Natur.456..663H</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnature07483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnature07483'" tppabs="https://doi.org/10.1038%2Fnature07483" class="external text external">10.1038/nature07483</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920208'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920208" class="external text external">2920208</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19005469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19005469'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19005469" class="external text external">19005469</a>.</cite></span></li><li id="cite_note-pmid12618500-75"> <span id="mw-reference-text-cite_note-pmid12618500-75" class="mw-reference-text"><cite id="CITEREFOsborneBardouHoppChamness2003" class="citation journal cs1">Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA,  et al. (March 2003). <a href="javascript:if(confirm('https://doi.org/10.1093/jnci/95.5.353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jnci/95.5.353'" tppabs="https://doi.org/10.1093/jnci/95.5.353" class="external text external">"Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer"</a>. <i>Journal of the National Cancer Institute</i>. <b>95</b> (5): 353–61. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjnci%2F95.5.353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjnci%2F95.5.353'" tppabs="https://doi.org/10.1093%2Fjnci%2F95.5.353" class="external text external">10.1093/jnci/95.5.353</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12618500  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12618500'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12618500" class="external text external">12618500</a>.</cite></span></li><li id="cite_note-urlwww.modernmedicine.com-76"> <span id="mw-reference-text-cite_note-urlwww.modernmedicine.com-76" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Mechanism-Predicts-Tamoxifen-Response/ArticleNewsFeed/Article/detail/565990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Mechanism-Predicts-Tamoxifen-Response/ArticleNewsFeed/Article/detail/565990'" tppabs="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Mechanism-Predicts-Tamoxifen-Response/ArticleNewsFeed/Article/detail/565990" class="external text external">"New Mechanism Predicts Tamoxifen Response: PAX2 gene implicated in tamoxifen-induced inhibition of ERBB2/HER2-mediated tumor growth"</a>. www.modernmedicine.com. 2008-11-13. <a href="javascript:if(confirm('https://web.archive.org/web/20110714111141/http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Mechanism-Predicts-Tamoxifen-Response/ArticleNewsFeed/Article/detail/565990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110714111141/http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Mechanism-Predicts-Tamoxifen-Response/ArticleNewsFeed/Article/detail/565990'" tppabs="https://web.archive.org/web/20110714111141/http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Mechanism-Predicts-Tamoxifen-Response/ArticleNewsFeed/Article/detail/565990" class="external text external">Archived</a> from the original on 2011-07-14<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-11-14</span></span>.</cite></span></li><li id="cite_note-urlCORDIS_:_News-77"> <span id="mw-reference-text-cite_note-urlCORDIS_:_News-77" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=30093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=30093'" tppabs="http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=30093" class="external text external">"Study sheds new light on tamoxifen resistance"</a>. <i>News</i>. CORDIS News. <a href="javascript:if(confirm('https://web.archive.org/web/20090220060249/http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=30093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090220060249/http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=30093'" tppabs="https://web.archive.org/web/20090220060249/http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=30093" class="external text external">Archived</a> from the original on 2009-02-20<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-11-14</span></span>.</cite></span></li><li id="cite_note-pmid27704479-78"> <span id="mw-reference-text-cite_note-pmid27704479-78" class="mw-reference-text"><cite id="CITEREFDuarteJalladBronstein2016" class="citation journal cs1">Duarte FH, Jallad RS, Bronstein MD (November 2016). "Estrogens and selective estrogen receptor modulators in acromegaly". <i>Endocrine</i>. <b>54</b> (2): 306–314. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12020-016-1118-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12020-016-1118-z'" tppabs="https://doi.org/10.1007%2Fs12020-016-1118-z" class="external text external">10.1007/s12020-016-1118-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27704479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27704479'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27704479" class="external text external">27704479</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:10136018  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:10136018'" tppabs="https://api.semanticscholar.org/CorpusID:10136018" class="external text external">10136018</a>.</cite></span></li><li id="cite_note-pmid15755972-79"> <span id="mw-reference-text-cite_note-pmid15755972-79" class="mw-reference-text"><cite id="CITEREFFabianKimler2005" class="citation journal cs1">Fabian CJ, Kimler BF (March 2005). "Selective estrogen-receptor modulators for primary prevention of breast cancer". <i>J. Clin. Oncol</i>. <b>23</b> (8): 1644–55. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2005.11.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2005.11.005'" tppabs="https://doi.org/10.1200%2FJCO.2005.11.005" class="external text external">10.1200/JCO.2005.11.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15755972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15755972'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15755972" class="external text external">15755972</a>.</cite></span></li><li id="cite_note-pmid23687971-80"> <span id="mw-reference-text-cite_note-pmid23687971-80" class="mw-reference-text"><cite id="CITEREFLiMaJiangWu2013" class="citation journal cs1">Li J, Ma Z, Jiang RW, Wu B (September 2013). "Hormone-related pharmacokinetic variations associated with anti-breast cancer drugs". <i>Expert Opin Drug Metab Toxicol</i>. <b>9</b> (9): 1085–95. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F17425255.2013.802771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F17425255.2013.802771'" tppabs="https://doi.org/10.1517%2F17425255.2013.802771" class="external text external">10.1517/17425255.2013.802771</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23687971  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23687971'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23687971" class="external text external">23687971</a>.</cite></span></li><li id="cite_note-pmid26023144-81"> <span id="mw-reference-text-cite_note-pmid26023144-81" class="mw-reference-text"><cite id="CITEREFProssnitzArterburn2015" class="citation journal cs1">Prossnitz ER, Arterburn JB (July 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017" class="external text external">"International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators"</a>. <i>Pharmacol. Rev</i>. <b>67</b> (3): 505–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fpr.114.009712  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fpr.114.009712'" tppabs="https://doi.org/10.1124%2Fpr.114.009712" class="external text external">10.1124/pr.114.009712</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017" class="external text external">4485017</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26023144  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26023144'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26023144" class="external text external">26023144</a>.</cite></span></li><li id="cite_note-pmid23824607-82"> <span id="mw-reference-text-cite_note-pmid23824607-82" class="mw-reference-text"><cite id="CITEREFLiuFlockhartLuLv2013" class="citation journal cs1">Liu J, Flockhart PJ, Lu D, Lv W, Lu WJ, Han X,  et al. (September 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876808  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876808'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876808" class="external text external">"Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifen"</a>. <i>Drug Metabolism and Disposition</i>. <b>41</b> (9): 1715–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fdmd.113.052506  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fdmd.113.052506'" tppabs="https://doi.org/10.1124%2Fdmd.113.052506" class="external text external">10.1124/dmd.113.052506</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876808  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876808'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876808" class="external text external">3876808</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23824607  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23824607'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23824607" class="external text external">23824607</a>.</cite></span></li><li id="cite_note-ZarateManji2009-83"> <span id="mw-reference-text-cite_note-ZarateManji2009-83" class="mw-reference-text"><cite id="CITEREFZarateManji2009" class="citation journal cs1">Zarate CA, Manji HK (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802274  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802274'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802274" class="external text external">"Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder"</a>. <i>CNS Drugs</i>. <b>23</b> (7): 569–82. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-200923070-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-200923070-00003'" tppabs="https://doi.org/10.2165%2F00023210-200923070-00003" class="external text external">10.2165/00023210-200923070-00003</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802274  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802274'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802274" class="external text external">2802274</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19552485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19552485'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19552485" class="external text external">19552485</a>.</cite></span></li><li id="cite_note-DeVitaLawrence2016-84"> <span id="mw-reference-text-cite_note-DeVitaLawrence2016-84" class="mw-reference-text"><cite id="CITEREFVincent_T._DeVitaTheodore_S._LawrenceSteven_A._Rosenberg2016" class="citation book cs1">Vincent T. DeVita; Theodore S. Lawrence; Steven A. Rosenberg (18 March 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Bf3DCwAAQBAJ&pg=PT990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Bf3DCwAAQBAJ&pg=PT990'" tppabs="https://books.google.com/books?id=Bf3DCwAAQBAJ&pg=PT990" class="external text external"><i>Prostate and Other Genitourinary Cancers: From Cancer: Principles &amp; Practice of Oncology, 10th edition</i></a>. Wolters Kluwer Health. pp.<span>&nbsp;</span>990–. ISBN<span>&nbsp;</span><bdi>978-1-4963-5421-1</bdi>.</cite></span></li><li id="cite_note-Nagar2010-85"> <span id="mw-reference-text-cite_note-Nagar2010-85" class="mw-reference-text"><cite id="CITEREFNagar2010" class="citation journal cs1">Nagar S (2010). "Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy". <i>Advances in Experimental Medicine and Biology</i>. <b>678</b>: 124–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-1-4419-6306-2_16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-1-4419-6306-2_16'" tppabs="https://doi.org/10.1007%2F978-1-4419-6306-2_16" class="external text external">10.1007/978-1-4419-6306-2_16</a>. ISBN<span>&nbsp;</span><bdi>978-1-4419-6305-5</bdi>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20738014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20738014'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20738014" class="external text external">20738014</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:12537667  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:12537667'" tppabs="https://api.semanticscholar.org/CorpusID:12537667" class="external text external">12537667</a>.</cite></span></li><li id="cite_note-Jordan1986-86"> <span id="mw-reference-text-cite_note-Jordan1986-86" class="mw-reference-text"><cite id="CITEREFVirgil_Craig_Jordan1986" class="citation book cs1">Virgil Craig Jordan (1986). <a href="javascript:if(confirm('https://books.google.com/books?id=7WmLZfGXST0C&pg=PA28  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=7WmLZfGXST0C&pg=PA28'" tppabs="https://books.google.com/books?id=7WmLZfGXST0C&pg=PA28" class="external text external"><i>Estrogen/antiestrogen Action and Breast Cancer Therapy</i></a>. Univ of Wisconsin Press. pp.<span>&nbsp;</span>28, 154. ISBN<span>&nbsp;</span><bdi>978-0-299-10480-1</bdi>.</cite></span></li><li id="cite_note-Pratt1994-87"> <span id="mw-reference-text-cite_note-Pratt1994-87" class="mw-reference-text"><cite id="CITEREFWilliam_B._Pratt1994" class="citation book cs1">William B. Pratt (1994). <a href="javascript:if(confirm('https://books.google.com/books?id=nPR1L4K5HuEC&pg=PA21  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=nPR1L4K5HuEC&pg=PA21'" tppabs="https://books.google.com/books?id=nPR1L4K5HuEC&pg=PA21" class="external text external"><i>The Anticancer Drugs</i></a>. Oxford University Press. pp.<span>&nbsp;</span>21–. ISBN<span>&nbsp;</span><bdi>978-0-19-506739-2</bdi>.</cite></span></li><li id="cite_note-MaximovMcDaniel2013-88"> <span id="mw-reference-text-cite_note-MaximovMcDaniel2013-88" class="mw-reference-text"><cite id="CITEREFPhilipp_Y._MaximovRussell_E._McDanielV._Craig_Jordan2013" class="citation book cs1">Philipp Y. Maximov; Russell E. McDaniel; V. Craig Jordan (23 July 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=p-W5BAAAQBAJ&pg=PA7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=p-W5BAAAQBAJ&pg=PA7'" tppabs="https://books.google.com/books?id=p-W5BAAAQBAJ&pg=PA7" class="external text external"><i>Tamoxifen: Pioneering Medicine in Breast Cancer</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>7–. ISBN<span>&nbsp;</span><bdi>978-3-0348-0664-0</bdi>.</cite></span></li><li id="cite_note-Ravina2011-89"> <span id="mw-reference-text-cite_note-Ravina2011-89" class="mw-reference-text"><cite id="CITEREFEnrique_Ravina2011" class="citation book cs1">Enrique Ravina (11 January 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA177'" tppabs="https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA177" class="external text external"><i>The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>177–178. ISBN<span>&nbsp;</span><bdi>978-3-527-32669-3</bdi>.</cite></span></li><li id="cite_note-CanoAlsina2006-90"> <span id="mw-reference-text-cite_note-CanoAlsina2006-90" class="mw-reference-text"><cite id="CITEREFAntonio_CanoJoacquim_Calaf_i_AlsinaJose_Luis_Duenas-Diez2006" class="citation book cs1">Antonio Cano; Joacquim Calaf i Alsina; Jose Luis Duenas-Diez (22 September 2006). <a href="javascript:if(confirm('https://books.google.com/books?id=heJDAAAAQBAJ&pg=PA52  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=heJDAAAAQBAJ&pg=PA52'" tppabs="https://books.google.com/books?id=heJDAAAAQBAJ&pg=PA52" class="external text external"><i>Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>52–. ISBN<span>&nbsp;</span><bdi>978-3-540-34742-2</bdi>.</cite></span></li><li id="cite_note-OrwollBilezikian2009-91"> <span id="mw-reference-text-cite_note-OrwollBilezikian2009-91" class="mw-reference-text"><cite id="CITEREFEric_S._OrwollJohn_P._BilezikianDirk_Vanderschueren2009" class="citation book cs1">Eric S. Orwoll; John P. Bilezikian; Dirk Vanderschueren (30 November 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=nfWNYFdOsCsC&pg=PA717  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=nfWNYFdOsCsC&pg=PA717'" tppabs="https://books.google.com/books?id=nfWNYFdOsCsC&pg=PA717" class="external text external"><i>Osteoporosis in Men: The Effects of Gender on Skeletal Health</i></a>. Academic Press. pp.<span>&nbsp;</span>717–. ISBN<span>&nbsp;</span><bdi>978-0-08-092346-8</bdi>.</cite></span></li><li id="cite_note-isbn0-471-89979-8-92"> <span id="mw-reference-text-cite_note-isbn0-471-89979-8-92" class="mw-reference-text"><cite id="CITEREFSneader2005" class="citation book cs1">Sneader W (2005). <i>Drug Discovery: A History</i>. New York: Wiley. p.<span>&nbsp;</span>472 pages. ISBN<span>&nbsp;</span><bdi>978-0-471-89979-2</bdi>.</cite></span></li><li id="cite_note-Jordan_2003-93"> <span id="mw-reference-text-cite_note-Jordan_2003-93" class="mw-reference-text"><cite id="CITEREFJordan2003" class="citation journal cs1">Jordan VC (March 2003). "Tamoxifen: a most unlikely pioneering medicine". <i>Nature Reviews. Drug Discovery</i>. <b>2</b> (3): 205–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrd1031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrd1031'" tppabs="https://doi.org/10.1038%2Fnrd1031" class="external text external">10.1038/nrd1031</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12612646  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12612646'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12612646" class="external text external">12612646</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:31333174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:31333174'" tppabs="https://api.semanticscholar.org/CorpusID:31333174" class="external text external">31333174</a>.</cite></span></li><li id="cite_note-urlUSA_Today-94"> <span id="mw-reference-text-cite_note-urlUSA_Today-94" class="mw-reference-text"><cite id="CITEREFKirk_E2002" class="citation web cs1">Kirk E (2002-07-24). <a href="javascript:if(confirm('https://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm'" tppabs="https://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm" class="external text external">"Dog's tale of survival opens door in cancer research"</a>. <i>Health and Behavior</i>. USA Today. <a href="javascript:if(confirm('https://web.archive.org/web/20080628110635/http://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080628110635/http://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm'" tppabs="https://web.archive.org/web/20080628110635/http://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm" class="external text external">Archived</a> from the original on 2008-06-28<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-06-24</span></span>.</cite></span></li><li id="cite_note-pmid11106254-95"> <span id="mw-reference-text-cite_note-pmid11106254-95" class="mw-reference-text"><cite id="CITEREFBlackwellHaroonShanSaito2000" class="citation journal cs1">Blackwell KL, Haroon ZA, Shan S, Saito W, Broadwater G, Greenberg CS, Dewhirst MW (November 2000). <a href="javascript:if(confirm('http://clincancerres.aacrjournals.org/cgi/content/abstract/6/11/4359  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clincancerres.aacrjournals.org/cgi/content/abstract/6/11/4359'" tppabs="http://clincancerres.aacrjournals.org/cgi/content/abstract/6/11/4359" class="external text external">"Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models"</a>. <i>Clinical Cancer Research</i>. <b>6</b> (11): 4359–64. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11106254  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11106254'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11106254" class="external text external">11106254</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20080906195254/http://clincancerres.aacrjournals.org/cgi/content/abstract/6/11/4359  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080906195254/http://clincancerres.aacrjournals.org/cgi/content/abstract/6/11/4359'" tppabs="https://web.archive.org/web/20080906195254/http://clincancerres.aacrjournals.org/cgi/content/abstract/6/11/4359" class="external text external">Archived</a> from the original on 2008-09-06.</cite></span></li><li id="cite_note-pmid12796359-96"> <span id="mw-reference-text-cite_note-pmid12796359-96" class="mw-reference-text"><cite id="CITEREFJensenJordan2003" class="citation journal cs1">Jensen EV, Jordan VC (June 2003). <a href="javascript:if(confirm('https://clincancerres.aacrjournals.org/content/9/6/1980.short  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincancerres.aacrjournals.org/content/9/6/1980.short'" tppabs="https://clincancerres.aacrjournals.org/content/9/6/1980.short" class="external text external">"The estrogen receptor: a model for molecular medicine"</a>. <i>Clin. Cancer Res</i>. <b>9</b> (6): 1980–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12796359  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12796359'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12796359" class="external text external">12796359</a>.</cite></span></li><li id="cite_note-HowellJordan2013-97"> <span id="mw-reference-text-cite_note-HowellJordan2013-97" class="mw-reference-text"><cite id="CITEREFHowellJordan2013" class="citation book cs1">Howell, Anthony; Jordan, V. Craig (2013). <a href="javascript:if(confirm('https://books.google.com/books?id=ZM26CgAAQBAJ&pg=PA229  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ZM26CgAAQBAJ&pg=PA229'" tppabs="https://books.google.com/books?id=ZM26CgAAQBAJ&pg=PA229" class="external text external">"Adjuvant Antihormone Therapy"</a>.  In Craig, Jordan V. (ed.). <i>Estrogen Action, Selective Estrogen Receptor Modulators And Women's Health: Progress And Promise</i>. World Scientific. pp.<span>&nbsp;</span>229–254. doi:<a href="javascript:if(confirm('https://doi.org/10.1142%2F9781848169586_0010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1142%2F9781848169586_0010'" tppabs="https://doi.org/10.1142%2F9781848169586_0010" class="external text external">10.1142/9781848169586_0010</a>. ISBN<span>&nbsp;</span><bdi>978-1-84816-959-3</bdi>.</cite></span></li><li id="cite_note-Cole_1971-98"> <span id="mw-reference-text-cite_note-Cole_1971-98" class="mw-reference-text"><cite id="CITEREFColeJonesTodd" class="citation journal cs1">Cole MP, Jones CT, Todd ID. "A new anti-oestrogenic agent in late breast cancer".</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-Ward_1973-99"> <span id="mw-reference-text-cite_note-Ward_1973-99" class="mw-reference-text"><cite id="CITEREFWard1973" class="citation journal cs1">Ward HW (January 1973). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1588574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1588574'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1588574" class="external text external">"Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels"</a>. <i>British Medical Journal</i>. <b>1</b> (5844): 13–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.1.5844.13  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.1.5844.13'" tppabs="https://doi.org/10.1136%2Fbmj.1.5844.13" class="external text external">10.1136/bmj.1.5844.13</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1588574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1588574'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1588574" class="external text external">1588574</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4567104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4567104'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4567104" class="external text external">4567104</a>.</cite></span></li><li id="cite_note-100"> <span id="mw-reference-text-cite_note-100" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.yorkshirepost.co.uk/news/features/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.yorkshirepost.co.uk/news/features/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838'" tppabs="http://www.yorkshirepost.co.uk/news/features/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838" class="external text external">"Maverick and pioneer whose work is improving odds in breast cancer fight"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20130628015824/http://www.yorkshirepost.co.uk/news/features/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130628015824/http://www.yorkshirepost.co.uk/news/features/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838'" tppabs="https://web.archive.org/web/20130628015824/http://www.yorkshirepost.co.uk/news/features/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838" class="external text external">Archived</a> from the original on 2013-06-28<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-11-05</span></span>.</cite></span></li><li id="cite_note-101"> <span id="mw-reference-text-cite_note-101" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.yorkshirepost.co.uk/news/analysis/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.yorkshirepost.co.uk/news/analysis/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838'" tppabs="http://www.yorkshirepost.co.uk/news/analysis/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838" class="external text external">"Maverick and pioneer whose work is improving odds in breast cancer fight"</a>. <i>The Yorkshire Post</i>. 27 June 2013. <a href="javascript:if(confirm('https://web.archive.org/web/20160309182447/http://www.yorkshirepost.co.uk/news/analysis/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160309182447/http://www.yorkshirepost.co.uk/news/analysis/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838'" tppabs="https://web.archive.org/web/20160309182447/http://www.yorkshirepost.co.uk/news/analysis/maverick-and-pioneer-whose-work-is-improving-odds-in-breast-cancer-fight-1-5799838" class="external text external">Archived</a> from the original on 2016-03-09<span class="reference-accessdate">. Retrieved <span class="nowrap">April 7,</span> 2017</span>.</cite></span></li><li id="cite_note-Baum_2003-102"> <span id="mw-reference-text-cite_note-Baum_2003-102" class="mw-reference-text"><cite id="CITEREFBaumBrinkleyDossettMcPherson1983" class="citation journal cs1">Baum M, Brinkley DM, Dossett JA, McPherson K, Patterson JS, Rubens RD,  et al. (August 1983). "Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer". <i>Lancet</i>. <b>2</b> (8347): 450. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2883%2990406-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2883%2990406-3'" tppabs="https://doi.org/10.1016%2FS0140-6736%2883%2990406-3" class="external text external">10.1016/S0140-6736(83)90406-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6135926  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6135926'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6135926" class="external text external">6135926</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:54230182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:54230182'" tppabs="https://api.semanticscholar.org/CorpusID:54230182" class="external text external">54230182</a>.</cite></span></li><li id="cite_note-FURR_1984-103"> <span id="mw-reference-text-cite_note-FURR_1984-103" class="mw-reference-text"><cite id="CITEREFFurrJordan1984" class="citation journal cs1">Furr BJ, Jordan VC (1984). "The pharmacology and clinical uses of tamoxifen". <i>Pharmacology &amp; Therapeutics</i>. <b>25</b> (2): 127–205. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0163-7258%2884%2990043-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0163-7258%2884%2990043-3'" tppabs="https://doi.org/10.1016%2F0163-7258%2884%2990043-3" class="external text external">10.1016/0163-7258(84)90043-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6438654  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6438654'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6438654" class="external text external">6438654</a>.</cite></span></li><li id="cite_note-104"> <span id="mw-reference-text-cite_note-104" class="mw-reference-text"><cite id="CITEREFJordan2001" class="citation journal cs1">Jordan VC (August 2001). "Selective estrogen receptor modulation: a personal perspective". <i>Cancer Research</i>. <b>61</b> (15): 5683–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11479197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11479197'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11479197" class="external text external">11479197</a>.</cite></span></li><li id="cite_note-105"> <span id="mw-reference-text-cite_note-105" class="mw-reference-text"><cite id="CITEREFLernerJordan1990" class="citation journal cs1">Lerner LJ, Jordan VC (July 1990). "Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture". <i>Cancer Research</i>. <b>50</b> (14): 4177–89. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2194650  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2194650'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2194650" class="external text external">2194650</a>.</cite></span></li><li id="cite_note-pmid9605801-106"> <span id="mw-reference-text-cite_note-pmid9605801-106" class="mw-reference-text"><cite id="CITEREFEarly_Breast_Cancer_Trialists'_Collaborative_Group1998" class="citation journal cs1">Early Breast Cancer Trialists' Collaborative Group (May 1998). "Tamoxifen for early breast cancer: an overview of the randomised trials". <i>Lancet</i>. <b>351</b> (9114): 1451–67. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2897%2911423-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2897%2911423-4'" tppabs="https://doi.org/10.1016%2FS0140-6736%2897%2911423-4" class="external text external">10.1016/S0140-6736(97)11423-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9605801  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9605801'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9605801" class="external text external">9605801</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:46287542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:46287542'" tppabs="https://api.semanticscholar.org/CorpusID:46287542" class="external text external">46287542</a>.</cite></span></li><li id="cite_note-Drugs.com-107"> <span id="mw-reference-text-cite_note-Drugs.com-107" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/tamoxifen.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/tamoxifen.html'" tppabs="https://www.drugs.com/international/tamoxifen.html" class="external text external">"Tamoxifen"</a>.</cite></span></li><li id="cite_note-urlCancer_the_generic_impact-108"> <span id="mw-reference-text-cite_note-urlCancer_the_generic_impact-108" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20080516032316/http://www.bioportfolio.com/news/datamonitor_16.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080516032316/http://www.bioportfolio.com/news/datamonitor_16.htm'" tppabs="https://web.archive.org/web/20080516032316/http://www.bioportfolio.com/news/datamonitor_16.htm" class="external text external">"Cancer the generic impact"</a>. BioPortfolio Limited. Archived from <a href="javascript:if(confirm('http://www.bioportfolio.com/news/datamonitor_16.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bioportfolio.com/news/datamonitor_16.htm'" tppabs="http://www.bioportfolio.com/news/datamonitor_16.htm" class="external text external">the original</a> on 2008-05-16<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-11-14</span></span>.</cite></span></li><li id="cite_note-urlwww.astrazeneca.se-109"> <span id="mw-reference-text-cite_note-urlwww.astrazeneca.se-109" class="mw-reference-text"><cite id="CITEREFVose_B" class="citation web cs1">Vose B. <a href="javascript:if(confirm('http://www.astrazeneca.com/_mshost3690701/content/resources/media/investors/2004-abr-brent-vose-oncology.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.astrazeneca.com/_mshost3690701/content/resources/media/investors/2004-abr-brent-vose-oncology.pdf'" tppabs="http://www.astrazeneca.com/_mshost3690701/content/resources/media/investors/2004-abr-brent-vose-oncology.pdf" class="external text external">"AstraZenecain Cancer: Slide #15"</a> <span class="cs1-format">(PDF)</span>. <i>AstraZeneca Annual Business Review</i>. www.astrazeneca.com. <a href="javascript:if(confirm('https://web.archive.org/web/20100131160325/http://astrazeneca.com/_mshost3690701/content/resources/media/investors/2004-abr-brent-vose-oncology.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100131160325/http://astrazeneca.com/_mshost3690701/content/resources/media/investors/2004-abr-brent-vose-oncology.pdf'" tppabs="https://web.archive.org/web/20100131160325/http://astrazeneca.com/_mshost3690701/content/resources/media/investors/2004-abr-brent-vose-oncology.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2010-01-31<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-28</span></span>. <q>2004 tamoxifen market share: 70% Source: IMS HEALTH, IMS MIDAS Monthly. July 2004. Aromatase Inhibitors + Tamoxifen</q></cite></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite id="CITEREFEugsterShankarFeezlePescovitz1999" class="citation journal cs1">Eugster EA, Shankar R, Feezle LK, Pescovitz OH (1999). "Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome". <i>Journal of Pediatric Endocrinology &amp; Metabolism</i>. <b>12</b> (5): 681–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2Fjpem.1999.12.5.681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2Fjpem.1999.12.5.681'" tppabs="https://doi.org/10.1515%2Fjpem.1999.12.5.681" class="external text external">10.1515/jpem.1999.12.5.681</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10703542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10703542'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10703542" class="external text external">10703542</a>.</cite></span></li><li id="cite_note-111"> <span id="mw-reference-text-cite_note-111" class="mw-reference-text"><cite id="CITEREFEugsterRubinReiterPlourde2003" class="citation journal cs1">Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, Pescovitz OH (July 2003). "Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial". <i>The Journal of Pediatrics</i>. <b>143</b> (1): 60–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0022-3476%2803%2900128-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0022-3476%2803%2900128-8'" tppabs="https://doi.org/10.1016%2FS0022-3476%2803%2900128-8" class="external text external">10.1016/S0022-3476(03)00128-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12915825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12915825'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12915825" class="external text external">12915825</a>.</cite></span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text"><cite id="CITEREFKreherEugsterShankar2005" class="citation journal cs1">Kreher NC, Eugster EA, Shankar RR (December 2005). "The use of tamoxifen to improve height potential in short pubertal boys". <i>Pediatrics</i>. <b>116</b> (6): 1513–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.2005-0577  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.2005-0577'" tppabs="https://doi.org/10.1542%2Fpeds.2005-0577" class="external text external">10.1542/peds.2005-0577</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16322179  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16322179'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16322179" class="external text external">16322179</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:45133251  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:45133251'" tppabs="https://api.semanticscholar.org/CorpusID:45133251" class="external text external">45133251</a>.</cite></span></li><li id="cite_note-pmid18348701-113"> <span id="mw-reference-text-cite_note-pmid18348701-113" class="mw-reference-text"><cite id="CITEREFKarimianChaginGjerdeHeino2008" class="citation journal cs1">Karimian E, Chagin AS, Gjerde J, Heino T, Lien EA, Ohlsson C, Sävendahl L (August 2008). "Tamoxifen impairs both longitudinal and cortical bone growth in young male rats". <i>Journal of Bone and Mineral Research</i>. <b>23</b> (8): 1267–77. doi:<a href="javascript:if(confirm('https://doi.org/10.1359%2Fjbmr.080319  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1359%2Fjbmr.080319'" tppabs="https://doi.org/10.1359%2Fjbmr.080319" class="external text external">10.1359/jbmr.080319</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18348701  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18348701'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18348701" class="external text external">18348701</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:35813153  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:35813153'" tppabs="https://api.semanticscholar.org/CorpusID:35813153" class="external text external">35813153</a>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><cite id="CITEREFChaginKarimianZamanTakigawa2007" class="citation journal cs1">Chagin AS, Karimian E, Zaman F, Takigawa M, Chrysis D, Sävendahl L (May 2007). "Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones". <i>Bone</i>. <b>40</b> (5): 1415–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bone.2006.12.066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bone.2006.12.066'" tppabs="https://doi.org/10.1016%2Fj.bone.2006.12.066" class="external text external">10.1016/j.bone.2006.12.066</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17293177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17293177'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17293177" class="external text external">17293177</a>.</cite></span></li><li id="cite_note-pmid16418409-115"> <span id="mw-reference-text-cite_note-pmid16418409-115" class="mw-reference-text"><cite id="CITEREFvan_BommelHendrikszHuiskesZeegers2006" class="citation journal cs1">van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG (January 2006). "Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis". <i>Annals of Internal Medicine</i>. <b>144</b> (2): 101–6. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-144-2-200601170-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-144-2-200601170-00007'" tppabs="https://doi.org/10.7326%2F0003-4819-144-2-200601170-00007" class="external text external">10.7326/0003-4819-144-2-200601170-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16418409  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16418409'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16418409" class="external text external">16418409</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:25699557  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:25699557'" tppabs="https://api.semanticscholar.org/CorpusID:25699557" class="external text external">25699557</a>.</cite></span></li><li id="cite_note-pmid17478346-116"> <span id="mw-reference-text-cite_note-pmid17478346-116" class="mw-reference-text"><cite id="CITEREFAkramPardiSchaffnerSmyrk2007" class="citation journal cs1">Akram S, Pardi DS, Schaffner JA, Smyrk TC (May 2007). "Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients". <i>Clinical Gastroenterology and Hepatology</i>. <b>5</b> (5): 589–96, quiz 523–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.cgh.2007.02.032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.cgh.2007.02.032'" tppabs="https://doi.org/10.1016%2Fj.cgh.2007.02.032" class="external text external">10.1016/j.cgh.2007.02.032</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17478346  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17478346'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17478346" class="external text external">17478346</a>.</cite></span></li><li id="cite_note-pmid12698518-117"> <span id="mw-reference-text-cite_note-pmid12698518-117" class="mw-reference-text"><cite id="CITEREFDabelicJukicLabarNovosel2003" class="citation journal cs1">Dabelic N, Jukic T, Labar Z, Novosel SA, Matesa N, Kusic Z (April 2003). <a href="javascript:if(confirm('http://www.cmj.hr/2003/44/2/12698518.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cmj.hr/2003/44/2/12698518.pdf'" tppabs="http://www.cmj.hr/2003/44/2/12698518.pdf" class="external text external">"Riedel's thyroiditis treated with tamoxifen"</a> <span class="cs1-format">(PDF)</span>. <i>Croatian Medical Journal</i>. <b>44</b> (2): 239–41. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12698518  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12698518'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12698518" class="external text external">12698518</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20080910130853/http://www.cmj.hr/2003/44/2/12698518.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080910130853/http://www.cmj.hr/2003/44/2/12698518.pdf'" tppabs="https://web.archive.org/web/20080910130853/http://www.cmj.hr/2003/44/2/12698518.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2008-09-10.</cite></span></li><li id="cite_note-pmid8855277-118"> <span id="mw-reference-text-cite_note-pmid8855277-118" class="mw-reference-text"><cite id="CITEREFFeilBrocardMascrezLeMeur1996" class="citation journal cs1">Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P (October 1996). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38252  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38252'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38252" class="external text external">"Ligand-activated site-specific recombination in mice"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>93</b> (20): 10887–90. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1996PNAS...9310887F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1996PNAS...9310887F'" tppabs="https://ui.adsabs.harvard.edu/abs/1996PNAS...9310887F" class="external text external">1996PNAS...9310887F</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.93.20.10887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.93.20.10887'" tppabs="https://doi.org/10.1073%2Fpnas.93.20.10887" class="external text external">10.1073/pnas.93.20.10887</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38252  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38252'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38252" class="external text external">38252</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8855277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8855277'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8855277" class="external text external">8855277</a>.</cite></span></li><li id="cite_note-TalaeiPourgholami2016-119"> <span id="mw-reference-text-cite_note-TalaeiPourgholami2016-119" class="mw-reference-text"><cite id="CITEREFTalaeiPourgholamiKhatibi-MoghadamFaridhosseini2016" class="citation journal cs1">Talaei A, Pourgholami M, Khatibi-Moghadam H, Faridhosseini F, Farhoudi F, Askari-Noghani A, Sadeghi R (June 2016). "Tamoxifen: A Protein Kinase C Inhibitor to Treat Mania: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials". <i>Journal of Clinical Psychopharmacology</i>. <b>36</b> (3): 272–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FJCP.0000000000000492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FJCP.0000000000000492'" tppabs="https://doi.org/10.1097%2FJCP.0000000000000492" class="external text external">10.1097/JCP.0000000000000492</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27088436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27088436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27088436" class="external text external">27088436</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:39792641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:39792641'" tppabs="https://api.semanticscholar.org/CorpusID:39792641" class="external text external">39792641</a>.</cite></span></li><li id="cite_note-SaxenaScaini2017-120"> <span id="mw-reference-text-cite_note-SaxenaScaini2017-120" class="mw-reference-text"><cite id="CITEREFSaxenaScainiBavarescoLeite2017" class="citation journal cs1">Saxena A, Scaini G, Bavaresco DV, Leite C, Valvassori SS, Carvalho AF, Quevedo J (November 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701269  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701269'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701269" class="external text external">"Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature"</a>. <i>Molecular Neuropsychiatry</i>. <b>3</b> (2): 108–124. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000480349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000480349'" tppabs="https://doi.org/10.1159%2F000480349" class="external text external">10.1159/000480349</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701269  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701269'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701269" class="external text external">5701269</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29230399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29230399'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29230399" class="external text external">29230399</a>.</cite></span></li><li id="cite_note-AdisInsight-Endoxifen-121"> <span id="mw-reference-text-cite_note-AdisInsight-Endoxifen-121" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800036114  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800036114'" tppabs="https://adisinsight.springer.com/drugs/800036114" class="external text external">"Endoxifen - Intas Pharmaceuticals/Jina pharmaceuticals - AdisInsight"</a>.</cite></span></li><li id="cite_note-pmid29207335-122"> <span id="mw-reference-text-cite_note-pmid29207335-122" class="mw-reference-text"><cite id="CITEREFShaguftaAhmad2018" class="citation journal cs1">Shagufta, Ahmad I (January 2018). "Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives". <i>Eur J Med Chem</i>. <b>143</b>: 515–531. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejmech.2017.11.056  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejmech.2017.11.056'" tppabs="https://doi.org/10.1016%2Fj.ejmech.2017.11.056" class="external text external">10.1016/j.ejmech.2017.11.056</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29207335  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29207335'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29207335" class="external text external">29207335</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFDean2014" class="citation book cs1">Dean L (2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK247013/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK247013/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK247013/" class="external text external">"Tamoxifen Therapy and CYP2D6 Genotype"</a>.  In Pratt VM, McLeod HL, Rubinstein WS,  et al. (eds.). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK61999/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK61999/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK61999/" class="external text external"><i>Medical Genetics Summaries</i></a>. National Center for Biotechnology Information (NCBI). PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28520357  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28520357'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28520357" class="external text external">28520357</a>. Bookshelf ID: NBK247013.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/tamoxifen  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/tamoxifen'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/tamoxifen" class="external text external">"Tamoxifen"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Estrogens_and_antiestrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogens_and_antiestrogens" style="font-size:114%;margin:0 4em">Estrogens and antiestrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Estrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li>Certain androgens/anabolic steroids (e.g., testosterone, testosterone esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone, nandrolone esters) (via estrogenic metabolites)</li>
<li>Certain progestins (e.g., <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a>, noretynodrel, <a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">etynodiol diacetate</a>, tibolone)</li>
<li>Clomestrone</li>
<li>Cloxestradiol acetate</li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Epiestriol</li>
<li>Epimestrol</li>
<li>Esterified estrogens</li>
<li>Estetrol<sup>†</sup></li>
<li>Estradiol</li>
<li>Estradiol esters (e.g., estradiol acetate, estradiol benzoate, estradiol cypionate, estradiol enanthate, estradiol undecylate, estradiol valerate, polyestradiol phosphate, estradiol ester mixtures (Climacteron))</li>
<li>Estramustine phosphate</li>
<li>Estriol</li>
<li>Estriol esters (e.g., estriol succinate, polyestriol phosphate)</li>
<li>Estrogenic substances</li>
<li>Estrone</li>
<li>Estrone esters
<ul><li>Estrone sulfate</li>
<li>Estropipate (piperazine estrone sulfate)</li></ul></li>
<li>Ethinylestradiol<sup>#</sup>
<ul><li>Ethinylestradiol sulfonate</li></ul></li>
<li>Hydroxyestrone diacetate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Nilestriol</li>
<li>Prasterone (dehydroepiandrosterone; DHEA)
<ul><li>Prasterone enanthate</li>
<li>Prasterone sulfate</li></ul></li>
<li>Promestriene</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Benzestrol</li>
<li>Bifluranol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol (stilbestrol)</a></li>
<li>Diethylstilbestrol esters/ethers
<ul><li>Dimestrol (diethylstilbestrol dimethyl ether)</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Mestilbol (diethylstilbestrol monomethyl ether)</li></ul></li>
<li>Doisynoestrol (fenocycline)</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol (promethestrol)
<ul><li>Methestrol dipropionate (promethestrol dipropionate)</li></ul></li>
<li>Paroxypropione</li>
<li>Quadrosilan</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiandrogens (e.g., <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr> (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <abbr>FSH</abbr>, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiestrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> antagonists<br>(incl. <abbr>SERMs</abbr>/<abbr>SERDs</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acolbifene<sup>†</sup></li>
<li>Anordrin</li>
<li>Bazedoxifene</li>
<li>Broparestrol</li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a><sup>#</sup></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li>Enclomifene<sup>†</sup></li>
<li>Epitiostanol</li>
<li>Lasofoxifene</li>
<li>Mepitiostane</li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a><sup>#</sup></li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li></ul>

<ul><li><i>Exclusively antagonistic:</i> <a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Aromatase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>First-generation:</i> <a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a></li></ul>

<ul><li><i>Second-generation:</i> Fadrozole</li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li></ul>

<ul><li><i>Third-generation:</i> <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Letrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Letrozole" title="Letrozole">Letrozole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens/anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>, testosterone esters, nandrolone esters, <a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">oxandrolone</a>, <a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">fluoxymesterone</a>)</li>
<li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>, <a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">goserelin</a>)</li>
<li><abbr>GnRH</abbr> antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>, elagolix)</li>
<li>Progestogens (e.g., chlormadinone acetate, cyproterone acetate, gestonorone caproate, hydroxyprogesterone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Mixed mechanism of action:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li></ul>

<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Estrogen receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of estrogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Estrogen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogen_receptor_modulators" style="font-size:114%;margin:0 4em">Estrogen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol</li>
<li>3α-Androstanediol</li>
<li><span class="new">3α,5α-Dihydrolevonorgestrel</span></li>
<li><span class="new">3β,5α-Dihydrolevonorgestrel</span></li>
<li>3α-Hydroxytibolone</li>
<li>3β-Hydroxytibolone</li>
<li>3β-Androstanediol</li>
<li><a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">4-Androstenedione</a></li>
<li>4-Fluoroestradiol</li>
<li>4-Hydroxyestradiol</li>
<li>4-Hydroxyestrone</li>
<li>4-Methoxyestradiol</li>
<li>4-Methoxyestrone</li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">5-Androstenediol</a></li>
<li>7-Oxo-DHEA</li>
<li>7α-Hydroxy-DHEA</li>
<li>7α-Methylestradiol</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>8,9-Dehydroestradiol</li>
<li>8,9-Dehydroestrone</li>
<li>8β-VE2</li>
<li>10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)</li>
<li>11β-Chloromethylestradiol</li>
<li>11β-Methoxyestradiol</li>
<li>15α-Hydroxyestradiol</li>
<li>16-Ketoestradiol</li>
<li>16-Ketoestrone</li>
<li>16α-Fluoroestradiol</li>
<li>16α-Hydroxy-DHEA</li>
<li>16α-Hydroxyestrone</li>
<li>16α-Iodoestradiol</li>
<li>16α-LE2</li>
<li>16β-Hydroxyestrone</li>
<li>16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)</li>
<li>17α-Estradiol (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">alfatradiol</a>)</li>
<li>17α-Dihydroequilenin</li>
<li>17α-Dihydroequilin</li>
<li>17α-Epiestriol (16α-hydroxy-17α-estradiol)</li>
<li>17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>17β-Dihydroequilenin</li>
<li>17β-Dihydroequilin</li>
<li>17β-Methyl-17α-dihydroequilenin</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Alestramustine</li>
<li>Almestrone</li>
<li>Anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> and esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone (methandrostenolone), <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, many others; via estrogenic metabolites)</li>
<li>Atrimustine</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Butolame</li>
<li>Clomestrone</li>
<li>Cloxestradiol
<ul><li>Cloxestradiol acetate</li></ul></li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Cyclodiol</li>
<li>Cyclotriol</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA-S</a></li>
<li><i>ent</i>-Estradiol</li>
<li>Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)</li>
<li>Epimestrol</li>
<li><a href="Equilenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilenin" title="Equilenin">Equilenin</a></li>
<li><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></li>
<li>ERA-63 (ORG-37663)</li>
<li>Esterified estrogens</li>
<li>Estetrol</li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a>
<ul><li>Estradiol esters</li>
<li>Lipoidal estradiol</li>
<li>Polyestradiol phosphate</li></ul></li>
<li><a href="Estramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Estramustine" title="Estramustine">Estramustine</a></li>
<li>Estramustine phosphate</li>
<li>Estrapronicate</li>
<li>Estrazinol</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a>
<ul><li>Estriol esters</li>
<li>Polyestriol phosphate</li></ul></li>
<li>Estrofurate</li>
<li>Estrogenic substances</li>
<li>Estromustine</li>
<li><a href="Estrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrone" title="Estrone">Estrone</a>
<ul><li>Estrone esters</li>
<li>Estrone methyl ether</li>
<li>Estropipate</li></ul></li>
<li>Etamestrol (eptamestrol)</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li>Ethinylestradiol
<ul><li>Ethinylestradiol 3-benzoate</li>
<li>Ethinylestradiol sulfonate</li></ul></li>
<li>Ethinylestriol</li>
<li>Ethylestradiol</li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Hexolame</li>
<li>Hippulin</li>
<li>Hydroxyestrone diacetate</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Mytatrienediol</li>
<li>Nilestriol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Noretynodrel</li>
<li>Orestrate</li>
<li>Pentolame</li>
<li>Prodiame</li>
<li>Prolame</li>
<li>Promestriene</li>
<li>RU-16117</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li>
<li>Tibolone</li></ul>

<ul><li><i>Nonsteroidal:</i> (R,R)-THC</li>
<li>(S,S)-THC</li>
<li>2,8-DHHHC</li>
<li><span class="new">β-LGND1</span></li>
<li>β-LGND2 (GTx-878)</li>
<li><span class="new">AC-186</span></li>
<li>Allenestrol</li>
<li>Allenolic acid</li>
<li>Benzestrol</li>
<li>Bifluranol</li>
<li>Bisdehydrodoisynolic acid</li>
<li>Butestrol</li>
<li>Carbestrol</li>
<li>D-15414</li>
<li>DCW234</li>
<li>Diarylpropionitrile</li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a>
<ul><li>Diethylstilbestrol esters</li></ul></li>
<li>Dimestrol (dianisylhexene)</li>
<li>Dimethylstilbestrol</li>
<li>Doisynoestrol (fenocycline)</li>
<li>Doisynolic acid</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>ERB-196 (WAY-202196)</li>
<li>Erteberel (SERBA-1, LY-500307)</li>
<li>Estrobin (DBE)</li>
<li>Fenestrel</li>
<li>FERb 033</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Furostilbestrol (diethylstilbestrol difuroate)</li>
<li>GTx-758</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li>ICI-85966 (Stilbostat)</li>
<li>M2613</li>
<li><i>meso</i>-Butestrol</li>
<li><i>meso</i>-Hexestrol</li>
<li>Mestilbol</li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol</li>
<li>Methestrol dipropionate</li>
<li>Paroxypropione</li>
<li>Pentafluranol</li>
<li>Phenestrol</li>
<li>Prinaberel (ERB-041, WAY-202041)</li>
<li>Propylpyrazoletriol</li>
<li>Quadrosilan</li>
<li><span class="new">SC-3296</span></li>
<li>SC-4289</li>
<li>SERBA-2</li>
<li>SKF-82,958</li>
<li>Terfluranol</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li>Triphenyliodoethylene</li>
<li>Triphenylmethylethylene (triphenylpropene)</li>
<li>WAY-166818</li>
<li><span class="new">WAY-169916</span></li>
<li>WAY-200070</li>
<li>WAY-204688 (SIM-688)</li>
<li>WAY-214156</li></ul>

<ul><li><i>Unknown/unsorted:</i> ERB-26</li>
<li>ERA-45</li>
<li>ERB-79</li>
<li>ZK-283197</li></ul>

<ul><li><i>Xenoestrogens:</i> <a href="Anise.htm" tppabs="https://ptable.com/wiki/compounds/A/Anise" title="Anise">Anise</a>-related (e.g., <a href="Anethole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anethole" title="Anethole">anethole</a>, anol, dianethole, dianol, photoanethole)</li>
<li>Chalconoids (e.g., <a href="Isoliquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoliquiritigenin" title="Isoliquiritigenin">isoliquiritigenin</a>, <a href="Phloretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phloretin" title="Phloretin">phloretin</a>, <a href="Phlorizin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phlorizin" title="Phlorizin">phlorizin (phloridzin)</a>, wedelolactone)</li>
<li>Coumestans (e.g., <a href="Coumestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumestrol" title="Coumestrol">coumestrol</a>, psoralidin)</li>
<li><a href="Flavonoid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavonoid" title="Flavonoid">Flavonoids</a> (incl. 7,8-DHF, 8-prenylnaringenin, <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">apigenin</a>, <a href="Baicalein.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalein" title="Baicalein">baicalein</a>, <a href="Baicalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalin" title="Baicalin">baicalin</a>, <a href="Biochanin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Biochanin_A" title="Biochanin A">biochanin A</a>, <a href="Calycosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Calycosin" title="Calycosin">calycosin</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">catechin</a>, <a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">daidzein</a>, daidzin, ECG, <a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">EGCG</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">epicatechin</a>, <a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">equol</a>, <a href="Formononetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Formononetin" title="Formononetin">formononetin</a>, glabrene, glabridin, <a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">genistein</a>, <a href="Genistin.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistin" title="Genistin">genistin</a>, <a href="Glycitein.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycitein" title="Glycitein">glycitein</a>, <a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">kaempferol</a>, <a href="Liquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Liquiritigenin" title="Liquiritigenin">liquiritigenin</a>, mirificin, <a href="Myricetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Myricetin" title="Myricetin">myricetin</a>, <a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">naringenin</a>, <span class="new">penduletin</span>, pinocembrin, <a href="Prunetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prunetin" title="Prunetin">prunetin</a>, puerarin, <a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">quercetin</a>, tectoridin, tectorigenin)</li>
<li>Lavender oil</li>
<li>Lignans (e.g., enterodiol, enterolactone, nyasol (<i>cis</i>-hinokiresinol))</li>
<li>Metalloestrogens (e.g., <a href="Cadmium.htm" tppabs="https://ptable.com/wiki/compounds/A/Cadmium" title="Cadmium">cadmium</a>)</li>
<li>Pesticides (e.g., alternariol, <a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">dieldrin</a>, <a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">endosulfan</a>, <a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">fenarimol</a>, HPTE, <a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">methiocarb</a>, <a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">methoxychlor</a>, <a href="Triclocarban.htm" tppabs="https://ptable.com/wiki/compounds/A/Triclocarban" title="Triclocarban">triclocarban</a>, triclosan)</li>
<li>Phytosteroids (e.g., <a href="Digitoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digitoxin" title="Digitoxin">digitoxin</a> (digitalis), <a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">diosgenin</a>, guggulsterone)</li>
<li><a href="Phytosterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Phytosterol" title="Phytosterol">Phytosterols</a> (e.g., β-sitosterol, <a href="Campesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Campesterol" title="Campesterol">campesterol</a>, <a href="Stigmasterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stigmasterol" title="Stigmasterol">stigmasterol</a>)</li>
<li>Resorcylic acid lactones (e.g., zearalanone, α-zearalenol, β-zearalenol, <a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">zearalenone</a>, <a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">zeranol (α-zearalanol)</a>, taleranol (teranol, β-zearalanol))</li>
<li>Steroid-like (e.g., deoxymiroestrol, miroestrol)</li>
<li>Stilbenoids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">resveratrol</a>, <a href="Rhaponticin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rhaponticin" title="Rhaponticin">rhaponticin</a>)</li>
<li>Synthetic xenoestrogens (e.g., alkylphenols, <a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">bisphenols</a> (e.g., <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">BPA</a>, BPF, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">BPS</a>), DDT, parabens, <a href="Polybrominated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polybrominated_biphenyl" title="Polybrominated biphenyl">PBBs</a>, PHBA, phthalates, <a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a>)</li>
<li>Others (e.g., agnuside, <span class="new">rotundifuran</span>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SERMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">2-Phenylbenzofuran</span></li>
<li><span class="new">2-Phenylbenzothiophene</span></li>
<li>4'-Hydroxynorendoxifen</li>
<li>27-Hydroxycholesterol</li>
<li>Acefluranol</li>
<li>Acolbifene</li>
<li>Afimoxifene</li>
<li>Anordiol</li>
<li>Anordrin</li>
<li>Arzoxifene</li>
<li>Bazedoxifene</li>
<li>Brilanestrant</li>
<li>Broparestrol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></li>
<li>Clomifenoxide</li>
<li><span class="new">CN-55945-27</span></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li><span class="new">D-15413</span></li>
<li>Desmethylchlorotrianisene</li>
<li>Droloxifene</li>
<li>Elacestrant</li>
<li>Enclomifene</li>
<li>Endoxifen</li>
<li>Etacstil (GW-5638, DPC-974)</li>
<li>Ethamoxytriphetol (MER-25)</li>
<li>Femarelle</li>
<li>Fispemifene</li>
<li><span class="new">GW-7604</span></li>
<li><span class="new">ICI-55548</span></li>
<li><a href="Idoxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxifene" title="Idoxifene">Idoxifene</a></li>
<li>Lasofoxifene</li>
<li>Levormeloxifene</li>
<li>LN-1643</li>
<li>LN-2299</li>
<li><span class="new">LY-117018</span></li>
<li>Menerba</li>
<li>Miproxifene</li>
<li>Miproxifene phosphate</li>
<li><span class="new">MRL-37</span></li>
<li>Nafoxidine</li>
<li>Nitromifene</li>
<li>NNC 45-0095</li>
<li><span class="new">NNC 45-0320</span></li>
<li><span class="new">NNC 45-0781</span></li>
<li><span class="new">NNC 45-1506</span></li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li>Panomifene</li>
<li>Pipendoxifene</li>
<li><span class="new">Promensil</span></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li>Rimostil (P-081)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li><span class="new">SS1010</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>TAS-108 (SR-16234)</li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li>
<li>Trioxifene</li>
<li><span class="new">TZE-5323</span></li>
<li><span class="new">U-11555A</span></li>
<li><span class="new">U-11634</span></li>
<li><span class="new">Y-134</span></li>
<li>Zindoxifene</li>
<li>Zuclomifene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(R,R)-THC</li>
<li>7β-Hydroxy-DHEA</li>
<li><span class="new">Chloroindazole</span></li>
<li>Cytestrol acetate</li>
<li><span class="new">EM-800 (SCH-57050)</span></li>
<li>Epitiostanol</li>
<li><span class="new">ERA-90</span></li>
<li><span class="new">ERB-88</span></li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><a href="Glyceollin.htm" tppabs="https://ptable.com/wiki/compounds/A/Glyceollin" title="Glyceollin">Glyceollins</a> (I, <span class="new">II</span>, III, <span class="new">IV</span>)</li>
<li>ICI-164384</li>
<li><span class="new">MDL-101906</span></li>
<li>Mepitiostane</li>
<li>Methylepitiostanol</li>
<li>Methylpiperidinopyrazole</li>
<li>MIBE</li>
<li><span class="new">Oxabicycloheptene sulfonate</span></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>PHTPP</li>
<li>Prochloraz</li>
<li><span class="new">RU-39411</span></li>
<li><span class="new">RU-58668</span></li>
<li><span class="new">SS1020</span></li>
<li>TAS-108 (SR-16234)</li>
<li>ZB716</li>
<li><span class="new">ZK-164015</span></li>
<li><span class="new">ZK-191703</span></li></ul>

<ul><li><i>Coregulator-binding modulators:</i> ERX-11</li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>7β-Hydroxyepiandrosterone</li>
<li>Afimoxifene (4-hydroxytamoxifen)</li>
<li><a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">Aldosterone</a></li>
<li><a href="Atrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atrazine" title="Atrazine">Atrazine</a></li>
<li><a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">Bisphenol A</a></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li>DDT (p,p'-DDT, <span class="new">o',p'-DDE</span>)</li>
<li>Diarylpropionitrile</li>
<li><a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">Equol</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li>Ethinylestradiol</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><span class="new">G-1</span></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><span class="new">GPER-L1</span></li>
<li><span class="new">GPER-L2</span></li>
<li>Hydroxytyrosol</li>
<li><a href="Kepone.htm" tppabs="https://ptable.com/wiki/compounds/A/Kepone" title="Kepone">Kepone</a></li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li><a href="Nicotinamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinamide" title="Nicotinamide">Nicotinamide</a></li>
<li><a href="Nonylphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nonylphenol" title="Nonylphenol">Nonylphenol</a></li>
<li><a href="Oleuropein.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleuropein" title="Oleuropein">Oleuropein</a></li>
<li><a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a> (<span class="new">2,2',5'-PCB-4-OH</span>)</li>
<li>Propylpyrazoletriol</li>
<li><a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">Quercetin</a></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">Resveratrol</a></li>
<li><span class="new">STX</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Tectoridin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CCL18</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a></li>
<li><span class="new">G-15</span></li>
<li><span class="new">G-36</span></li>
<li>MIBE</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Unknown</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li>
<li><a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">Zearalenone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of estrogens</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="AstraZeneca" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="AstraZeneca" style="font-size:114%;margin:0 4em">AstraZeneca</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Atenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Atenolol" title="Atenolol">Atenolol</a></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">Brompheniramine</a></li>
<li><a href="Budesonide.htm" tppabs="https://ptable.com/wiki/compounds/A/Budesonide" title="Budesonide">Budesonide</a></li>
<li>Disufenton sodium</li>
<li><a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">Esomeprazole</a></li>
<li>FluMist</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li>
<li><a href="Gefitinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Gefitinib" title="Gefitinib">Gefitinib</a></li>
<li><a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">Goserelin</a></li>
<li><a href="Isosorbide_mononitrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Isosorbide_mononitrate" title="Isosorbide mononitrate">Isosorbide mononitrate</a></li>
<li>Motavizumab</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li>Palivizumab</li>
<li><a href="Propofol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propofol" title="Propofol">Propofol</a></li>
<li><a href="Rosuvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Ticagrelor</li>
<li>Vandetanib</li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Ximelagatran" title="Ximelagatran">Ximelagatran</a></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">Zolmitriptan</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Predecessors and<br>acquired companies</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Astra AB</li>
<li>Cambridge Antibody Technology</li>
<li>MedImmune</li>
<li>Zeneca</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tom McKillop</li>
<li>Louis Schweitzer</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="font-weight: bold;"><div>
<ul><li><figure-inline><span><img src="../I/m/Folder_Hexagonal_Icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Folder_Hexagonal_Icon.svg.png" data-file-width="36" data-file-height="31" data-file-type="drawing" height="14" width="16"></span></figure-inline> Category</li>
<li><figure-inline><span><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="16" width="12"></span></figure-inline> <a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Category:AstraZeneca  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Category:AstraZeneca'" tppabs="https://commons.wikimedia.org/wiki/Category:AstraZeneca" title="commons:Category:AstraZeneca" class="external">Commons</a></li></ul>
</div></td></tr></tbody></table></div>

















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-06" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Tamoxifen&oldid=971425213  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Tamoxifen&oldid=971425213'" tppabs="https://en.wikipedia.org/wiki/?title=Tamoxifen&oldid=971425213">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>